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Abstract
Since the 1980’s, surrogacy has become a popular reproductive alternative for
individuals experiencing infertility. The ethical and legal analyses of surrogacy have been
rich and varied. Some bioethicists have charged the commercial surrogacy industry with the
exploitation of global southern women or with the impermissible commodification of
children and women’s reproductive capacities. Others have praised the potential for
economic empowerment and bodily autonomy that surrogacy may accord to women.
However, throughout these explorations of the ethics of surrogacy, comparatively little
attention has been paid to the moral status of a crucial actor: the fertility doctor. Without
doctors willing to provide prenatal and postnatal care to surrogates and make use of assisted
reproductive technologies (ARTs), commercial surrogacy would not take place. Yet, doctors’
involvement in surrogacy is far from morally neutral. In my thesis, I aim to explore what
duties doctors have in the context of commercial surrogacy. To do so, I take up the
framework of fiduciary obligation. I argue that doctors have fiduciary obligations to
surrogates, and that these obligations shape if and when doctors can ethically facilitate
surrogacy.
My thesis is divided into four chapters. The first defends the view that the doctorpatient relationship is fiduciary in nature. The second chapter extends this view to the realm
of commercial surrogacy, arguing that doctors also owe the surrogates they treat fiduciary
obligations. The third chapter addresses a challenge posed by my view, namely that
surrogacy seems to place doctors in positions where they constantly face conflicts of interest,
and are therefore unable to uphold their fiduciary duty of loyalty to surrogates. I address this
i

concern by arguing that conflicts of interest are not inherent in surrogacy, but that surrogacy
arrangements must be substantially rethought in order to safeguard the doctor-surrogate
fiduciary relationship. The final chapter considers the obligations doctors have to the children
they help create through surrogacy and through assisted reproduction more generally.
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Introduction
Background
The ethics of surrogacy—a practice wherein a woman gestates a baby for another
1

individual or couple —have been hotly debated since at least the 1980’s, when the Baby
2

M custody case attracted a great deal of attention in the news. Since then, commercial
surrogacy has become a booming transnational industry. The legal status of surrogacy is
variable, leading infertile individuals or couples to travel with increasing frequency from
countries such as Japan or France, where commercial surrogacy is illegal, to more
permissive countries such as Ukraine and South Africa to hire women to gestate babies
3

for them. This has created a lucrative global market for surrogacy services.

1

As I will explain below, using the term ‘surrogacy’ to describe this practice is somewhat

controversial.
2

The Baby M case was a custody case wherein a woman named Mary Beth Whitehead,

who had agreed to be a traditional surrogate for a couple named William and Elizabeth
Stern, made a parental claim over the child she gave birth to, known as Baby M. After a
protracted legal battle, custody was awarded to the Sterns, and visitation rights were
granted to Mary Beth Whitehead.
3

For instance, prior to recent changes in their surrogacy legislation, the surrogacy

industry in India alone was estimated to be worth between 445 million and 2 billion
dollars a year (Knoche 2014).

2

Opinion has remained deeply divided on the moral status of surrogacy. Some
have been optimistic about surrogacy’s potential, both to help infertile individuals form
families (Gostin 1988) and also to economically empower women (Teman 2001).
However, many others have decried surrogacy, claiming that it exploits and commodifies
women or that it amounts to ‘baby-selling’ (Anderson 1990, 2000; Tong 1990; Radin
1996). Although many feminists have considered ways to ameliorate surrogacy practices,
especially as they occur transnationally, their work often begins not with an affirmation
of surrogacy’s moral permissibility, but rather with a reluctant admission that surrogacy
will not stop any time soon (Parks 2010, Overall 2015).
In my thesis, I discuss surrogacy in a manner that moves away from this
seemingly intractable debate about the moral status of surrogacy. Instead of arguing
about whether surrogacy is permissible all things considered, I aim to explore whether
surrogacy is a practice in which it is permissible for fertility doctors to become involved.
Fertility doctors play an integral role in surrogacy arrangements, making use of a range of
assisted reproductive technologies (ARTs) to enable surrogate pregnancies and providing
surrogates with pre- and postnatal care. Without the participation of health care
professionals, surrogacy simply would not take place.

4

4

That is, gestational surrogacy would not take place. It may still be possible for some

traditional surrogacy arrangements to take place, but this form of surrogacy is far less
popular. I explain the gestational/traditional distinction below.

3

Doctors’ participation in surrogacy arrangements raises many potential concerns.
As I will explain, fertility doctors may often find themselves torn between the interests of
the commissioning couple and the interests of the surrogate when it comes to decisions
about the number of embryos to transfer, what genetic tests should be performed, what
birth method to pursue, and whether to recommend selective reductions in cases of
multiple pregnancy. How should doctors navigate these difficult situations? What duties
do doctors have if they become involved in surrogacy, and to whom do these duties
attach? Is it possible for doctors to uphold their duties to all of the parties involved in
surrogacy arrangements? I aim to answer these questions in my thesis.
There have been a few discussions of doctors’ role in surrogacy in the bioethics
literature. To the best of my knowledge, the earliest bioethical work on this topic comes
from Karen Rothenberg (1988, 1990), who considers various moral and legal questions
brought up by the Baby M case. She argues that health care providers should ultimately
refrain from participating in surrogacy, claiming that the ethical and legal risks inherent
in surrogacy cannot be minimized (Rothenberg 1990, 350). In a later paper on surrogacy
in Israel, Rosalie Ber (2000) suggests, among other things, that it is not necessarily
unethical for doctors to participate in surrogacy arrangements, but that the same doctor
should not simultaneously treat both the surrogate and the commissioning couple to avoid
conflicts of interest. Judith Daar (2014) and Samia Rafique and Alan DeCherney (2014)
also address doctors’ role in surrogacy, but they consider a narrower question: what
should fertility doctors do when a surrogate discloses that she has engaged in behaviour
that violates her surrogacy contract? Daar argues that the doctor is justified in informing
the commissioning couple of the breach without the surrogate’s consent, and Rafique and
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DeCherney claim that a doctor should not agree to hold the disclosure back from the
surrogate’s medical record, despite knowing that the commission couple would have
access to it.
Although these discussions engage with some troubling aspects of doctors’
participation in surrogacy, none provide a clear foundation for grounding fertility
5

doctors’ duties in the surrogacy context. I suspect that this lack of foundation helps
explain why these bioethicists draw such different conclusions about doctors’
participation in surrogacy. Ber seems to suggest that doctors’ involvement in surrogacy is
not inherently problematic, while Rothenberg concludes that their involvement is always
morally dubious. On the other hand, Daar and Rafique and DeCherney seem to take for
granted that there is nothing wrong with doctors facilitating surrogacy arrangements, and
focus more on how to resolve specific conflicts between surrogates and commissioning
couples. Without a normative framework for specifying and justifying fertility doctors’
duties, it is difficult to determine what—if any— of doctors’ actions are permissible in
the surrogacy context.

5

Ber, at times, references principlism —a moral system that appeals to the principles of

autonomy, beneficence, non-maleficence, and justice—in her discussion of surrogacy
(154, 160, 165). However, as Ber points out, principlism alone does not provide guidance
as to how various conflicts in surrogacy should be resolved. For example, she claims,
“When one speaks of autonomy—whose autonomy?—That of the genetic parents or that
of the surrogate mother? When one deals with beneficence—beneficence toward whom?
—the genetic parents or the surrogate mother or the child?” (160).

5

To provide such a foundation, I will employ the framework of fiduciary
obligation. This approach takes inspiration from a claim Rothenberg makes regarding the
possibility that fertility doctors might feel obliged to monitor surrogates’ conduct to
ensure that they live up to the terms of their surrogacy contracts. Rothenberg states,
disapprovingly, that the doctor ends up taking on “the role of spy, rather than the
fiduciary role to the patient” (1990, 350). The notion that fertility doctors act as
fiduciaries to surrogates provides a promising start for grounding doctors’ duties.
Rothenberg does not provide any further comment as to what it means to be a fiduciary or
6

how taking on the ‘fiduciary role’ should guide doctors’ conduct. However, as I will
argue, if fertility doctors truly are fiduciaries to the surrogates they treat, then their
obligations extend far beyond a duty of confidentiality, which of course prohibits
‘spying.’ I contend that the framework of fiduciary obligation, properly understood, can
provide a robust normative basis for grounding doctors’ duties in the surrogacy context.
Following legal theorists such as Paul B. Miller, I will argue that fiduciary
relationships are normative relationships that arise when an individual (the fiduciary)
exercises discretionary authority over the significant practical interests of another (the
beneficiary). Being in such relationships imposes strict obligations upon fiduciaries. In
particular, fiduciaries are obligated to uphold the duty of loyalty, which includes the

6

Rothenberg seems to treat the term ‘fiduciary’ as merely a byword for a relationship of

confidence. In general, bioethicists often use ‘fiduciary’ to simply mean a doctor-patient
relationship or a relationship of trust (Pellegrino 1991; Zaner 1991). Yet, as I will argue,
the term ‘fiduciary’ has a much more precise meaning.

6

requirement that fiduciaries use their discretionary power for the sole benefit of their
beneficiaries and the duty to avoid conflicts of interest (Frankel 2011). I will argue that
the relationship between doctors and surrogates meets P. B. Miller’s definition of the
fiduciary relationship, and that recognizing doctors’ duty of loyalty offers guidance as to
what constitutes permissible and impermissible conduct in the context of surrogacy
arrangements. Importantly, I will argue that although many surrogacy practices
undermine doctors’ ability to act as loyal fiduciaries, their participation in surrogacy can
be acceptable if significant reforms of those practices take place.
Outline of Chapters
Chapter 1:
In the first chapter, I defend the fiduciary characterization of the doctor-patient
relationship. I begin by outlining both what it means for a relationship to be fiduciary and
why fiduciaries are obligated to act loyally to their beneficiaries. Then, I explain why the
doctor-patient relationship should be understood as a fiduciary relationship, and respond
to two objections to this view. The first objection is that fiduciary relationships appear to
be paternalistic and are therefore at odds with the goal of promoting patient autonomy
(the paternalism objection). I respond to this worry by arguing that although a degree of
paternalism may be present in fiduciary relationships, some forms of paternalism are not
incompatible with patient autonomy. The second objection is that in the contemporary
health care system (especially with the rise of managed care), doctors’ allegiances will be
necessarily divided, leaving them unable to act as loyal fiduciaries (the divided loyalties
objection). I respond to this concern by claiming that having multiple loyalties is not
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synonymous with having divided loyalties. Doctors’ loyalties are only divided when, I
claim, they are motivated by self-interest or by other interests that do not stem from their
professional role qua doctors. I conclude that the relationship between doctors and their
patients is indeed fiduciary in nature.
Chapter 2:
In the second chapter, I argue that the relationship between doctors and surrogates should
also be viewed as fiduciary. First, I provide an account of the doctor-surrogate
relationship in practice, and give a provisional explanation as to why surrogates should be
viewed as patients. In light of my arguments in Chapter 1, I claim that if the doctorsurrogate relationship is a doctor-patient relationship, then it too should be viewed as
fiduciary. Then, I consider an objection to this view, the difference position objection,
which holds that the moral duties doctors have towards their patients do not necessarily
apply to their relationship with commercial surrogates since the two undertakings have
distinct goals and natures. To respond to this objection, I argue that regardless of whether
the goals of commercial surrogacy are distinct from those of therapeutic medical practice,
doctors still wield discretionary authority over surrogates’ significant practical interests.
Therefore, the doctor-surrogate relationship satisfies the fiduciary principle, and fertility
doctors should owe surrogates fiduciary obligations.
Chapter 3:
In the third chapter, I explore the implications of viewing the doctor-surrogate
relationship as fiduciary. Given the conflicts of interest that abound in surrogacy, I
question whether it is possible for doctors to actually act as loyal fiduciaries to
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surrogates. That is, I address whether it is ever ethical for doctors to agree to participate
in commercial surrogacy arrangements. First, I explore some of the most troubling threats
to doctors’ fiduciary loyalty that appear in surrogacy. These include conflicts that arise in
cases of ‘dual treatment’ (where the same doctor treats a commissioning individual or
couple and their surrogate simultaneously), conflicts that result from the influence of
commissioning couples’ interests, and financial conflicts of interest. I argue that although
these conflicts appear to be ubiquitous in surrogacy arrangements, they are not intrinsic to
surrogacy. Drawing from literature on two other ‘dual obligation’ contexts—live organ
donation and sports medicine—I propose solutions aimed at insulating the doctorsurrogate fiduciary relationship from conflicts of interest. These include creating greater
financial and clinical distance between the commissioning couple and the surrogate’s
doctor, and adopting a standard of single embryo transfer to avoid the risk that clinics
will aim to improve pregnancy success rates by transferring multiple embryos. Bringing
these recommendations into effect may make commercial surrogacy a more uncertain
prospect for commissioning couples since they would be unable to have direct input into
medical decisions made about the surrogate’s conception or pregnancy. Moreover, my
recommendations would also likely increase the costs associated with surrogacy because
having sufficient clinical distance requires the involvement of additional medical
professionals to provide parties with independent care. However, I argue that these
changes are needed to enable doctors to participate in commercial surrogacy without
violating their fiduciary obligations to surrogates.
Chapter 4:
In the final chapter, I consider whether fertility doctors have obligations to the children
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they help create through surrogacy and also through assisted reproduction more
generally. First, I argue that the interests of future children are at stake in decisions about
who is granted access to assisted reproduction and how those technologies are employed.
I then explore, but ultimately reject, a causal account of why doctors might be responsible
for protecting future children’s interests. I argue that it is not the causal role that doctors
play in the creation of children, but rather the discretionary power doctors wield over
potential future children’s interests that is relevant when considering doctors’ duties. I
argue that this power can be understood as fiduciary authority when it is granted to
doctors by the state out of recognition that future children’s interests are highly
vulnerable to the uses (or misuses) of assisted reproductive technologies. Thus, I
conclude that fertility doctors have a fiduciary mandate to act in the interests of the future
children they help create. However, I argue that this authority only extends over preconception decision-making, and therefore would not provide justification for doctors’
overriding pregnant women’s autonomy.
Finally, I address two objections to this account. The first is another form of the
divided loyalties objection. The interests of prospective fertility patients (surrogates or
infertile individuals) and of the future children potentially created through assisted
reproduction may not align. (They would not align, for example, if the infertile individual
was demonstrably unfit to parent a child.) If a fertility doctor has fiduciary obligations to
both parties, then this may give rise to a conflict of interest, which the duty of loyalty
proscribes. To address this objection, I return to my earlier claim that not all instances of
multiple loyalties result in conflicts of interest. Multiple loyalties only amount to divided
loyalties when a fiduciary is influenced by a secondary interest for reasons external to the
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fiduciary’s professional role (for instance, if the fiduciary is motivated by self-interest). I
argue that fertility doctors are entrusted with the responsible use of assisted reproductive
technologies, which includes considering the welfare of future children created through
them, as part of their professional mandate to act in the public good. Just as lawyers are
not disloyal to their clients when they act as officers of the court, fertility doctors are not
disloyal to their patients when they refuse to use ARTs in a manner that would harm
potential future children.
The second objection concerns an issue that falls under the umbrella of the ‘nonidentity’ problem. That is, my view has the counterintuitive implication that a fertility
doctor could act in the best interests of a future child by refusing to bring him or her into
existence. I address this problem by arguing that fertility doctors’ duties to future children
are structural rather than interpersonal. In other words, doctors’ duties attach to whoever
ends up occupying the position of ‘future child,’ not to any particular, identifiable future
person.
Terminology
Before I launch into my first chapter, it is useful to clarify some of the terms I will use.
First, the term ‘surrogacy’ is not uncontroversial. As Amrita Pande (2010) notes,
The origin of the term “surrogacy” and its social and political implications have
been widely discussed by feminists (Stanworth 1987; Snowdon 1994; Rothman
2000). Generally, a surrogate is defined as a substitute or a replacement, implying
that the surrogate is a substitute mother. Critics have argued that this terminology
suggests that the woman who is paid to give birth is somehow less than a mother
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and that this disparages her efforts and objectifies her by reducing her to her
reproductive capabilities. (970)
Similarly, Deborah Satz (1992) rejects the term ‘surrogate’ on the grounds that it has
loaded implications regarding who is a ‘real’ mother. However, following Pande, I use
the terms ‘surrogacy’ and ‘surrogate’ for the sake of brevity and because they are widely
used in the literature. At the same time, I acknowledge that other terms, such as ‘contract
pregnant women’ or ‘women who give birth/gestate for pay’ may be conceptually
preferable.
There are also distinctions drawn between different types of surrogacy. One
distinction is between traditional and gestational surrogacy. Traditional surrogacy
involves the use of a surrogate’s own eggs, in conjunction with the sperm of either a
commissioning man or third party donor. On the other hand, gestational surrogacy
involves the use of either a contracting woman’s eggs, or eggs from a third party donor,
in conjunction with the sperm of either a commissioning man or third party donor.
Another distinction is between paid and altruistic surrogacy. Altruistic surrogacy
arrangements often occur within families or amongst friends, while paid arrangements
primarily occur between strangers. In altruistic arrangements, surrogates can sometimes
receive reimbursements, such as for medical expenses, but they are not paid for providing
gestational services. Both traditional and gestational surrogacy can be either paid or
altruistic.
I focus here on paid gestational surrogacy, and use the terms ‘surrogacy’ or
‘commercial surrogacy’ to connote paid gestational surrogacy arrangements. I focus on
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this form of surrogacy for two reasons. First, gestational surrogacy is more common than
traditional surrogacy, and much of the recent surrogacy research concerns gestational
surrogacy. Second, the commercialization of surrogacy can introduce potential conflicts
that aren’t present, or are present to a lesser degree, in altruistic surrogacy. That said,
some of the ethical issues I will discuss will certainly transcend the gestational/traditional
or altruistic/commercial divisions, and many of the arguments I make will likely be
relevant for discussions of altruistic and traditional surrogacy, not just for commercial
and gestational surrogacy. Moreover, I acknowledge that altruistic surrogacy can take
place within commercialized fertility markets.
I use the term ‘commissioning individual or couple’ to refer to the individual(s)
who hire surrogates for the purposes of gestating their future children. Some other terms
are used in the literature, such as ‘intended parents.’ However, I use the language of
‘commissioning individual or couple’ because I am specifically discussing paid surrogacy
arrangements, and also because the term is neutral when it comes to the parentage of the
children produced through such arrangements. Sometimes, I simply write
‘commissioning couple’ for brevity, but a single person may, of course, also hire a
surrogate.
Finally, when I refer to the infertile individuals seeking out surrogacy services,
this may include not only individuals who face fertility issues as a result of medical
conditions, but also those who wish to have children but cannot for social reasons (for
instance, single individuals or gay couples). This is often referred to as ‘social infertility’
(Heyder 2015).
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Chapter 1

1

Doctors as Fiduciaries

The moral underpinnings of the doctor-patient relationship have long been a topic of
heated debate amongst philosophers, legal theorists, and healthcare professionals. It is
generally accepted that doctors have ethical duties to their patients. However, specifying
the content and nature of these duties has proven controversial. In this chapter, I argue
that the doctor-patient relationship is fiduciary in nature, and that doctors therefore owe
their patients fiduciary obligations. I begin by explaining what a fiduciary relationship is,
and why it matters whether a relationship counts as fiduciary. I defend the position
advocated for by Paul B. Miller (2011), which defines the fiduciary relationship as a
relationship wherein “one person exercises discretionary authority to set or pursue
practical interests… of another” (278). I then explain why the doctor-patient relationship
ought to be regarded as fiduciary. I argue that doctors are authorized to wield
considerable discretionary power over the health interests of patients, and that the doctorpatient relationship is therefore normatively fiduciary. Then, I respond to two concerns
one may have with the fiduciary understanding of the doctor-patient relationship. The
first is that fiduciary relationships are paternalistic and therefore at odds with the goal of
promoting patient autonomy (the paternalism objection) (Dworkin 2003). I will respond
to this worry by arguing that although some paternalism is present in fiduciary
relationships, a degree of paternalism is not necessarily incompatible with patient
autonomy. The second concern is that in the contemporary health care system (especially
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with the rise of managed care), doctors’ allegiances will be necessarily divided, leaving
them unable to act as loyal fiduciaries (the divided loyalties objection) (Rodwin 1995). I
will respond to this concern by claiming that having multiple loyalties is not synonymous
with having divided loyalties. What is important, I claim, is that doctors are not
motivated by self-interest, or by other interests that do not stem from their professional
role qua doctors.

1.1

What Are Fiduciary Relationships?

There is a great deal of disagreement amongst philosophers, legal theorists, and
lawmakers as to the precise definition of the fiduciary relationship. As Matthew Harding
(2013) claims, “Isolating that which makes a relationship fiduciary is one of the great
unfinished tasks of modern legal scholarship” (85). According to Sonia Allan and
Meredith Blake (2013), “[t]he term ‘fiduciary relationship’ has consistently escaped
definition” (316). Similarly, Tamar Frankel (2011) points out that “[r]arely do court
decisions and legislation provide a general definition of fiduciary relationships” (1).
Fiduciary relationships are roughly understood as relationships wherein one party
exercises power over another, and wherein the empowered party undertakes to act in the
interests of the other. However, such an understanding is too vague to provide precise
guidance as to what particular relationships ought to count as fiduciary.
Historically, courts have adopted one of two common approaches to identifying
relationships as fiduciary: the status-based approach and the fact-based approach. The
status-based approach is the older of the two, and is most widely used across
jurisdictions. As the name implies, it classifies relationships as fiduciary based on status
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or convention (Gold and P. B. Miller 2014, 2). It proceeds by categorizing a given
relationship and then determining whether the category of relationship itself is typically
regarded as fiduciary (P. B. Miller 2011, 241). For instance, a court may look at a given
relationship between Person A and Person B and determine that Person A is acting as a
trustee for the benefit of Person B. Since the relationship between trustees and
beneficiaries is conventionally regarded as fiduciary, courts would recognize the
relationship between Person A and Person B as fiduciary, and therefore as falling under
the scope of fiduciary law. According to this approach, new types of fiduciary
relationships are recognized by analogy. That is, in order for a type of relationship to be
considered fiduciary, it must be shown to be sufficiently analogous to paradigm examples
of fiduciary relationships.
However, this approach to fiduciary relationships has been criticized on the
grounds that it is overly narrow and rigid, and that it offers no clear explanation as to why
these types of relationships should be treated as distinctive. In the landmark Supreme
Court of Canada case Guerin v. The Queen, Justice Dickson argues in the majority holding
that the range of relationships that ought to be regarded as fiduciary are “not exhausted by
the standard categories of agent, trustee, partner, director, and the like” that are picked
out by the status-based approach (Guerin v. The Queen [1983] 2 SCR 335, qtd. in P. B.
Miller 2011, 242). He claims that the specific category of actor involved is not what gives
rise to fiduciary duties. Rather, it is the nature of the relationship itself that is important
(ibid).
Yet, rather than attempt to provide a precise definition of what makes a
relationship fiduciary, Canadian courts developed an approach to identifying fiduciary

16

relationships that looks to the specific facts of given relationships, rather than the status
of the actors involved. This approach, referred to by P. B. Miller as the fact-based
approach, views fiduciary obligations, as Justice La Forest puts it, as potentially arising
“as a matter of fact out of the specific circumstances of a relationship” (LAC Minerals
Ltd v. International Corona Resources Ltd [1989] 2 SCR 574). This approach seeks to
identify fiduciary relationships by virtue of their “possession of certain characteristics or
indicia of recognized fiduciary relationships” (P. B. Miller 2011, 243). In Frame v. Smith,
Justice Wilson provides an initial list of potential fiduciary indicia:
(1) The fiduciary has scope for the exercise of some discretion or power.
(2) The fiduciary can unilaterally exercise that power or discretion so as to affect
the beneficiary’s legal or practical interests.
(3) The beneficiary is peculiarly vulnerable to or at the mercy of the fiduciary
holding the discretion or power. 7 (Frame v Smith [1987] 2 SCR 99, qtd. in P.

7

Frankel (2011) provides another example of an approach based in recognized indicia.

She proposes identifying fiduciary relationships by a set of common factors:
First, fiduciaries offer mainly services (in contrast to products). The services that
fiduciaries offer are usually socially desirable, and often require expertise, such as
healing, legal services, teaching, asset management, corporate management, and
religious services. Second, in order to perform these services effectively,
fiduciaries must be entrusted with property or power. Third, entrustment poses to
entrustors the risks that the fiduciaries will not be trustworthy. They may
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B. Miller 2011, 243).
However, since Frame v. Smith, Canadian courts have remained divided as to whether or
not these are suitable indicia for fiduciary relationships. Many Supreme Court of Canada
cases on fiduciary relationships have been fraught with disagreement as to what features
are essential to fiduciary relationships. The relevance of vulnerability, for instance, is a
point of contention, with Justice Sopinka affirming its central importance to fiduciary
relationships in LAC Minerals Ltd. v. International Corona Resources Ltd. and Justice La

misappropriate the entrusted property or misuse the entrusted power or they will
not perform the promised services adequately. Fourth, there is likelihood that (1)
the entrustor will fail to protect itself from the risks involved in fiduciary
relationships; (2) the markets may fail to protect entrustors from these risks; and
that (3) the costs for the fiduciaries of establishing their trustworthiness may be
higher than their benefits from the relationships. (19-20)
While much more detailed than the Frame v. Smith indicia, Frankel’s criteria are
nonetheless intended to be more descriptive than explanatory. Some of the emerging
fiduciary relationships she discusses, like relationships between spouses, would likely not
be covered under her proposed definition since these relationships do not involve the
provision of services that require expertise. Although Frankel’s definition is useful
insofar as it highlights some common features of many fiduciary relationships, it still
stands to be supplemented by a definition with more explanatory force.
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Forest rejecting its necessity for the establishment of a fiduciary relationship in
Hodgkinson v. Simms (P. B. Miller 2011, 244-246).8
Thus, although the fact-based approach marks progress insofar as it directs
attention to the essential characteristics of fiduciary relationships, it nonetheless fails to
provide a fiduciary principle (P. B. Miller 2011, 249). The absence of such a principle is
problematic because it leaves courts without a clear way of determining what makes a
given relationship fiduciary (or indeed, why fiduciary relationships should be viewed as a
distinctive kind of relationship at all). Since lawyers and judges treat the fiduciary
relationship as the basis for imposing fiduciary obligations, like the duty of loyalty
(which I will explain below), an approach that makes clear why the fiduciary relationship
is distinctive is needed (P. B. Miller 2015, 69).
To fill this explanatory gap, P. B. Miller proposes a principled definition of
fiduciary relationships that focuses on the importance of discretionary power. He claims
that, “a fiduciary relationship is one in which one party (the fiduciary) enjoys
discretionary power over the significant practical interests of another (the beneficiary)”
(P. B. Miller 2011, 262). He asserts that although the Supreme Court of Canada has been
committed to the status-based and fact-based approaches, it “has repeatedly suggested
that the essential characteristic of fiduciary relationships lies in the discretionary power
wielded by fiduciaries over beneficiaries” (P. B. Miller 2011, 261). For example, in

8

See Duggan (2010) for a summary of the intellectual disagreements in Canadian courts

about the nature of fiduciary relationships.
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Norberg v. Wynrib, Justice McLachlin states that “the essence of a fiduciary
relationship ... is that one party exercises power on behalf of another” (Norberg v. Wynrib
[1992] 2 SCR 226, qtd. in P. B. Miller 2011, 261). In particular, P. B. Miller stresses the
ruling made by Justice Cromwell in Galambos v. Perez, which states that because the
appellant did not wield discretionary power over the practical interests of the respondent,
there was no fiduciary relationship between them (P. B. Miller 2011, 263). This emphasis
on discretionary power is consistent with Harding’s (2013) view that reliance on
discretion is the common feature of fiduciary relationships.
P. B. Miller offers some refinements to this general definition of the fiduciary
principle. First, he clarifies that by ‘fiduciary power’, he means the authority to act
relative to an individual’s practical interests (P. B. Miller 2011, 272). In arriving at his
understanding of ‘power as authority’, P. B. Miller distinguishes between three
conceptions of the word ‘power’. ‘Power’ can be understood as simply having access to
the practical interests of another; as having the capacity to affect or influence the practical
interests of another; or as having the authority to act relative to the practical interests of
another. Although these understandings are mutually consistent, P. B. Miller favors the
third definition of power as authority. To have the ‘authority to act relative to the
practical interests of another’ means to have the power to stand in substitution for another
in exercising a legal capacity (P. B. Miller 2015, 70). A legal capacity consists in both the
ability to act in a legally effective way and also to be held legally responsible for that
action. Legal capacities can include, for example, the capacity to enter into a legally
binding relationship or the capacity to make decisions relating to one’s health and
welfare. In the context of a fiduciary relationship, fiduciaries are granted the authority to
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exercise certain legal capacities on behalf of their beneficiaries. Fiduciary power,
understood in this way, consists in “the substitutive exercise of legal capacity” (P. B. Miller
2015, 71).

According to P. B. Miller, this view of fiduciary power as authority best coheres
with certain requirements of fiduciary relationships.9 For instance, fiduciary power is
purposive. Regardless of whether a fiduciary relationship is established through
agreement, undertaking, or decree, it is initiated for a reason (i.e. to advance or set the
interests of the beneficiary) (P. B. Miller 2011, 273). Therefore, when a fiduciary
exercises power, that exercise must be consistent with the purposes for which it is held
(Fox-Decent 2005, 301). While individuals can have access to or influence over another’s
practical interests by chance (as the first two conceptions of power would allow), the
same cannot be said for authority. Authority does not, as P. B. Miller puts it, “subsist at
large;” rather it “must be reposed, undertaken, or prescribed” (2011, 273). It would make
no sense to claim that someone could exercise a legal capacity on behalf of another

9

Lionel Smith (2014) makes a somewhat similar claim about fiduciary power in his

discussion of the duty of loyalty. Smith understands fiduciary relationships as
relationships wherein a given individual has the authority to exercise decision-making
power on behalf of another. He claims that “the requirement of loyalty is not imposed to
control mere power over another person; it is imposed to control decision-making power
held for, or on behalf of, another person” (Smith 2014, 8). Smith emphasizes the
importance of having the authority to act on behalf of someone, rather than simply having
the power to affect someone’s interests.
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merely by chance. Viewing fiduciary power as authority also makes it clear why
fiduciary relationships entail such strong, prophylactic duties, such as the duty to avoid
conflicts of interest (as in detail discussed below). When one party has authority over
another’s interests, there is a considerable imbalance of power. This imbalance makes the
person over whom the authority is held uniquely vulnerable to the use, or abuse, of that
power, and thus in particular need of protection (P. B. Miller 2011, 274, 281). Finally, P.
B. Miller adds that authority, in the fiduciary context, is relational. Fiduciaries do not
have unlimited discretion in the exercise of their authority. Rather, the scope of their
discretionary power lies precisely within the limits of the authority reposed in or
undertaken by them (P. B. Miller 2011, 275).
Having refined his understanding of fiduciary power as authority, P. B. Miller
then explains what he means by significant ‘practical interests’. He claims that “an
interest is practical where it connotes a real, ascertainable matter of personality, welfare,
or right in relation to which one person may be uniquely and materially susceptible to the
exercise of authority by another” (2011, 276). By matters of personality, P. B. Miller
means aspects of an individual’s legal personality. Legal personality is an individual’s
ability to hold legal obligations or rights, and it is a prerequisite for having legal
capacities. Matters of personality are not limited to capable individuals, but can also
pertain to incapable or artificial persons, such as children, comatose patients, or
corporations. Unlike matters of personality and rights, matters of welfare are limited to
natural persons, and include aspects of their personal integrity and well-being, such as
their physical and mental health. Defining practical interests as such is important since it
limits what interests can legitimately be subject to the exercise of fiduciary power (P. B.
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Miller 2011, 275). Understanding practical interests in this narrow way prevents the
category of fiduciary relationships from being overly inclusive. Granting your personal
trainer the power to choose on your behalf what kinds of exercises you will do, for
instance, would not count as a conferral of fiduciary authority since the interest you have
in doing particular kinds of exercise is a relatively trivial interest.
P. B. Miller also elaborates upon the use of fiduciary powers within a fiduciary
relationship. He explains that “[f]iduciaries have variously been deemed to hold power to
serve, to protect, or to promote or advance the practical interests of beneficiaries, or to
exercise them for or on behalf of beneficiaries” (2011, 276). All of these expressions, he
claims, attempt to get at something fundamental, which is that fiduciary power is
legitimately exercised in service of beneficiaries’ practical interests. There are two ways
in which this can occur. A fiduciary can either exercise her powers in the pursuit of her
beneficiaries’ ends (such as a lawyer working to get her client a favorable settlement) or
for the sake of setting her beneficiaries’ ends (such as a corporate director determining a
company’s ends when developing long-term business strategies) (P. B. Miller 2011, 277).
Thus, P. B. Miller arrives at a more focused definition of the fiduciary relationship: a
relationship in which “one person exercises discretionary authority to set or pursue
practical interests (including matters of personality, welfare or right) of another” (2011,
278).
Understanding fiduciary relationships in this way makes it clear why they are
different from other relationships that involve the exercise of discretionary power over
another’s interests. Trust between friends is a useful comparison. Imagine that my friend,
knowing that I am a financially savvy person, asks me to help her pick out a financial
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advisor. She trusts that, as a good friend, I will use my knowledge to help lead her in the
right direction. In this case, I have a form of discretionary power over her interests since I
could harm her financial interests if I intentionally led her astray (for instance, by
recommending she hire an advisor whom I know to be incompetent). However, our
relationship does not satisfy the fiduciary principle. Although she trusts me to help her
achieve her ends, I don’t have the power to set or pursue her interests. I am advising her
based on my personal experience with financial advisors, but I am not acting on her
behalf. Therefore, the power I have cannot be meaningfully understood as authority. The
influence I have over her interests is a somewhat natural result of our trusting friendship.
It is not something she has bestowed upon me for the purpose of achieving her ends.
Comparing P. B. Miller’s fiduciary principle to other attempts at defining the
fiduciary relationship also highlights this explanatory advantage of Miller’s account.
Take, for instance, a view expressed by Maxwell Mehlman (2015). Mehlman (2015)
claims that,
Fiduciary obligations are imposed in relationships in which one party, the
fiduciary, is in a position to take advantage of the other party, called the
beneficiary, principal, or “entrustor,” and in which the interests of the entrustors
that are at stake are important to society and sometimes vital to the entrustors’
welfare. (2)
On a certain interpretation of this definition, Mehlman’s view is compatible with P. B.
Miller’s; indeed in footnote 2, he presents his understanding of the term ‘interests’ as
reflective of P. B. Miller’s understanding of ‘significant practical interests.’ However,
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Mehlman’s definition is less refined and generally less useful than P. B. Miller’s. For one
thing, it is overly broad. It is possible for someone to be in a position to take advantage of
another party with regards to their vital interests in the context of a relationship that ought
not to be considered fiduciary. Imagine a Jack and the Beanstalk-esque example. The old
man in the fairy-tale who is attempting to sell Jack magic beans in exchange for his cow
(which represents his family’s entire livelihood) is clearly in a position to take advantage
of him. Jack’s interest in being able to support himself and his family, which is vital to
his welfare and important to society, is at stake. But it would make little sense to think of
the relationship between Jack and the old man as fiduciary, even though Jack trusts him,
and he can take advantage of that trust in a way that harms Jack’s vital interests. On its
own, then, Mehlman’s view fails to pick out what exactly makes the fiduciary
relationship distinctive from other relationships of trust, power, vulnerability, or
influence. P. B. Miller’s view, on the other hand, imbeds within the definition of the
fiduciary relationship an account of the distinguishing quality of fiduciary power—
having the authority to set or pursue someone’s significant practical interests.
It is interesting to note that fiduciary relationships, understood in this way, can
arise in the absence of any contract between parties, or even in the absence of explicit
consent. For instance, many jurisdictions recognize the relationship between parents and
children as fiduciary, even though most children never agree to being in such a
relationship. Evan Fox-Decent (2005) explains,
[I]n the parent-child case, it is the law itself which deems the fiduciary to act on
the basis of the beneficiary’s trust… It is sufficient, in appropriate circumstances,
that the fiduciary has discretionary control over the vulnerable interests of another
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party which themselves are capable of forming the subject matter of a fiduciary
obligation. (294)
This feature of the fiduciary relationship makes clear how a fiduciary model of the
doctor-patient relationship will differ from a contractual model. Unlike contractual
relationships, fiduciary relationships can arise from the circumstances of a situation. If
one party is intentionally exercising discretionary authority over the significant practical
interests of another, then she is acting as a fiduciary, regardless of whether or not she is
aware of that fact or has consented to it.
Such a discussion illuminates how fiduciary relationships have both legal and
moral dimensions. As Frankel (2011) points out, fiduciary duties carry with them an
“aura of morality” (104). She claims that, “as compared to breach of contract, a breach of
fiduciary duties carries a moral stigma and stricter legal consequences” (ibid). For
instance, she points to United States v. Iannone (184 F.3d 214 [3d Cir. 1999]), a case
where the defendant defrauded his investors by using their money for his own personal
expenses. Pursuant to the United States Sentencing Guidelines, the U.S. District Court for
the District of Columbia ruled to enhance the sentences for Iannone’s crimes in part
because they found that he abused the trust of his victims, who had relied upon his
integrity. In other words, the violation was punished harshly not just because it was a
criminal offense (i.e. fraud), but also, it seems, because it was a moral offense (i.e. a
betrayal of trust).
Finally, although it is the law that enforces fiduciary obligations, it is possible for
a relationship to satisfy the fiduciary principle (and thus be normatively fiduciary) in
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jurisdictions where that particular relationship is not recognized as fiduciary by the law.
When it comes to the doctor-patient relationship, I will focus primarily on the argument
that normatively speaking, the relationship between doctors and their patients is
fiduciary, regardless of whether this is reflected in the law. This is an important point
moving forward since not all jurisdictions will treat the doctor-patient relationship as
falling squarely within the category of ‘fiduciary.’ Given this diversity across
jurisdictions, I restrict my claims primarily to the normative dimensions of the fiduciary
relationship.

10

However, I contend that the law ought to recognize the doctor-patient

relationship as fiduciary (though providing a thorough legal argument for this claim is
beyond the scope of my project).
Having outlined P. B. Miller’s fiduciary principle, I now turn to briefly fleshing
out the obligations entailed by the fiduciary relationship. Like the fiduciary principle, the
precise set of fiduciary duties has also been the topic of much debate. Fiduciary duties
aim at protecting beneficiaries who are vulnerable to the misuse or abuse of discretionary
powers. Frankel’s work on fiduciary duties provides a useful starting point for
understanding these obligations. She divides fiduciary duties into two broad categories—
those relating to the ‘duty of loyalty’ and those relating to the ‘duty of care’. However,
there is debate as to whether the duty of care is a distinctively fiduciary duty, given that
non-fiduciary agents can be obligated to exercise a duty of care. For instance, landowners

10

See section 1.2 below for a discussion of how different jurisdictions approach the

question of whether the doctor-patient relationship is fiduciary.
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can have a duty of care towards people who come onto their premises, but the
relationship between a landowner and a person who happens upon their property is not
fiduciary.11 On the other hand, virtually all commentators agree that loyalty is the most
important or defining fiduciary duty (Smith 2014, 2). Therefore, for my purposes, I will
focus primarily on the duty of loyalty.
According to Frankel, the duty of loyalty comprises two aspects—the requirement
that fiduciaries use their discretionary power for the sole benefit of their beneficiaries,
and the prohibition on fiduciaries from acting in conflict with the interests of their
beneficiaries (insofar as those actions relate, that is, to the interests over which the
fiduciary has discretionary power) (Frankel 2011, 108).

11

12

The duty of loyalty, she

See Conaglen (2011) for a more detailed discussion as to why the duty of care isn’t

necessarily a fiduciary duty.
12

A fiduciary may, of course, act contrary to her beneficiary’s interests when those

interests have nothing to do with their fiduciary relationship. My divorce lawyer may
humiliate me by trouncing me in a tennis match without thereby violating her fiduciary
obligations to me. Complete selflessness on the part of the fiduciary is not what loyalty
requires. Rather, loyalty requires that whenever a fiduciary exercises the discretionary
power she has over her beneficiary’s interests, she does so only to achieve the ends for
which she was granted that power in the first place—that is, to set or pursue her
beneficiary’s relevant practical interests.
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claims, grounds a number of additional duties, including the duty to act in good faith, the
duty of confidentiality, and the duty to disclose relevant information to the beneficiary.
Why is it that fiduciaries are obligated to act loyally? In particular, why must
fiduciaries avoid conflicts of interest, rather than just skillfully navigate them? The duty
of loyalty is commonly viewed as being founded upon a beneficiary’s vulnerability to her
fiduciary (P. B. Miller 2011, 255). Given the structure of the fiduciary relationship, there
is a clear power imbalance between the beneficiary and the fiduciary. The beneficiary
must depend upon the fiduciary’s exercise of discretionary power, and her interests may
be severely harmed if that power is misused or abused. The duty of loyalty is a response
to this particular kind of structural vulnerability that is inherent in fiduciary relationships.
As P. B. Miller explains,
The duty of loyalty conditions the exercise of discretionary power, requiring it not
to be exercised other than for the benefit of the beneficiary. It responds to and
reflects a kind of vulnerability peculiar to the fiduciary relationship; namely, the
inherent susceptibility of the beneficiary to exploitative exercise of discretionary
power by the fiduciary. (2011, 280)
In other words, the duty of loyalty aims to protect beneficiaries from the risk that
fiduciaries will use their power to advance some end other than the beneficiary’s interests
(for example, personal profit). This duty includes the obligation to avoid conflicts of
interest in order, as Irit Samet (2008) puts it, to prevent fiduciaries “from getting involved
in situations in which the chances of committing a breach of duty are high” (764). That is,
conflicts of interest must be avoided because they threaten not only a fiduciary’s
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willingness to use her discretionary power solely in the interests of her beneficiary, but
also her capacity to do so. As Samet points out, given what moral psychology has taught
us about self-deception, even virtuous fiduciaries should refrain from placing themselves
in situations where there is a clear risk that a secondary interest may, on some level,
13

unduly shape their exercise of discretionary power.

The duty of loyalty is also what sets fiduciary obligations apart from other types
of obligations that stem from the exercise of discretionary power. For instance, recall the
example of my friend asking for advice about selecting a financial advisor. Since our
relationship is not fiduciary, I’m not obligated to give her advice in a way that is free
from self-interest. I could legitimately recommend that she look into an advisor who I
think is excellent, and who I know also invests in companies that align with my moral
commitments (even if I know my friend doesn’t care much one way or the other about
these particular commitments). Acting in this partially self-interested manner—
encouraging my friend to invest in a way that both benefits her and also advances my
other ethical commitments—wouldn’t violate my obligation to my friend since trust
14

relationships, unlike fiduciary relationships, don’t require strict loyalty.

13

See Samet (2008) for a more in-depth exploration of conflicts of interest and the risk of

self-deception.
14

As an honest friend, however, I should likely inform her that my moral commitments

influenced my recommendation.
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1.2

The Fiduciary Characterization of the Doctor-

Patient Relationship
Having outlined the fiduciary relationship, I now turn to defending the view that the
doctor-patient relationship is fiduciary. In the law, there is considerable disagreement
across jurisdictions about whether or not the doctor-patient relationship falls into the
fiduciary category. This disagreement may stem from the aforementioned lack of clarity
in courts surrounding what exactly makes a relationship fiduciary. In Canadian law, the
doctor-patient relationship is often recognized as fiduciary. For instance, in McInerney v.
MacDonald, the ruling makes it clear that the doctor-patient relationship is understood as
fiduciary. It held:
The physician-patient relationship is fiduciary in nature and certain duties arise from
that special relationship of trust and confidence. These include the duties of the
doctor to act with utmost good faith and loyalty, to hold information received from
or about a patient in confidence, and to make proper disclosure of information to the
patient. (McInerney v. MacDonald [1992] 2 SCR 138, my emphasis)
Thus, McInerney v. MacDonald seems to establish that the doctor-patient relationship is
fiduciary. Another influential Canadian case is Norberg v. Wynrib. In this case, the
appellant was addicted to painkillers, and had been receiving them from her doctor in
exchange for sexual favors. She sought “general and punitive damages against the
respondent on the grounds of sexual assault, negligence, breach of fiduciary duty and
breach of contract” (Norberg v. Wynrib [1992] 2 SCR 226). Although she was awarded
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damages, the majority stopped short of recognizing the relationship in question as
fiduciary. The previous court of appeal was unwilling to categorize their relationship as
fiduciary, and since the Supreme Court of Canada ruling dealt with the case as a matter of
assault, the potentially fiduciary nature of the relationship was not revisited. However, in
a concurring minority opinion, Justice McLaughlin does engage with the fiduciary
question. She upholds the decision from McInerney v. MacDonald about the fiduciary
status of the doctor-patient relationship, claiming that “the most fundamental characteristic
of the doctor-patient relationship is its fiduciary nature. All the authorities agree that the
relationship of physician to patient also falls into that special category of relationships which
the law calls fiduciary” (Norberg v. Wynrib [1992] 2 SCR 226).
In contrast, Australian courts are hesitant to regard the doctor-patient relationship as
15

fiduciary. Take, for example, the ruling in Breen v. Williams.

In this case, the appellant

was involved in a class action lawsuit, and required a copy of her medical records as part
of that litigation. Her doctor refused to provide her with her records in a manner she
deemed acceptable (Brebner 1998, 238). The court ruled against her, claiming that, “The
relationship between a doctor and patient is not, in this State, “the same relationship as
that which exists in equity between the persons in question: it is not ‘a fiduciary for trust
relationship’ as those terms are used in the law of this State” (Breen v. Williams, above n
61, at 566.). The ruling on Breen v. Williams accepted that the doctor-patient relationship

15

The circumstances of Breen v. Williams bear similarity to McInerney v. MacDonald

insofar as both revolve around patient access to medical records.
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exhibited some of the characteristics of a fiduciary relationship (Allan and Blake 2014,
316-317). However, the judges did not alter the existing Australian position, deciding to
refrain from placing the doctor-patient relationship squarely into the fiduciary category.
English courts too have been resistant to the notion that the doctor-patient relationship is
fiduciary. In Sidaway v. Bethlem, Lord Scarman pronounced that the appellant’s attempt
to persuade the court that the relationship between a doctor and patient is fiduciary “fails:
there is no comparison to be made between the relationship of doctor and patient with
that of solicitor and client, trustee and cestui qui trust16 or other relationships treated in
equity as of a fiduciary character” (Sidaway v. Bethlem Royal Hospital Governors [1985]
AC 871, qtd. in Bartlett 1997, 193).
Surveying the state of fiduciary law across various jurisdictions regarding the
doctor-patient relationship makes it all the more clear that a principled definition of the
fiduciary relationship, like the one P. B. Miller provides, is needed. Using either statusbased approaches (as do English, Australian, and sometimes Canadian courts) or factbased approaches (as do Canadian courts at other times) cannot seem to answer the
question of whether, at least normatively speaking, the doctor-patient relationship should
be understood as fiduciary.17 However, by adopting P. B. Miller’s fiduciary principle, the
justification for the fiduciary characterization of the doctor-patient relationship becomes

16

That is, the beneficiary of the trust.

17

For a useful summary of how doctors have been considered fiduciaries under law

(including, in terms of property law, as advisers, or as agents), see Frances Miller (1983).
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clear. Recall that P. B. Miller defines a fiduciary relationship as a relationship in which
one person exercises discretionary authority to set or pursue the significant practical
interests of another. Given this definition, there are several questions that must be
answered about the doctor-patient relationship in order to determine whether or not it is
fiduciary: Does a doctor exercise discretionary power? Is that power held relative to a
patient’s significant practical interests? And finally, is that power understood as the
authority to set or pursue those practical interests? I will answer these questions in turn.
First, the doctor-patient relationship does, necessarily, involve a doctor exercising
discretionary power. A doctor typically exercises a host of powers, such as the powers to
perform tests, diagnose illnesses, provide treatments, and take medical histories (which
may involve the disclosure of sensitive personal information). The exercise of these
powers is discretionary in nature since patients typically lack the relevant medical
knowledge to evaluate or ‘check up on’ their doctors’ decisions and, as I will explain
below, since doctors require flexibility to make certain judgment calls in the course of
treatment.
A common example of how doctors exercise discretion is found in their decisions
about what medical information should be provided to patients so that they can give
informed consent to treatment. Informed consent is a cornerstone of ethical medical
decision-making and care. However, since patients often have a limited understanding of
medicine, doctors must make discretionary judgments in determining what information is
needed to effectively inform them. Indeed, doctors may struggle to “strike a balance
between too much and too little information” (Murray 2012, 563). Thus, although
patients have the final say when it comes to choosing amongst treatment options, doctors
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make a multitude of discretionary judgments before they even present patients with those
options. While patients can, and often do, get second opinions, they must ultimately rely
upon at least one doctor’s discretionary judgment if they wish to receive medical
treatment.
Moreover, since every human body is different, medical treatments and
procedures can have unpredictable results, and doctors must have the freedom to adapt to
new circumstances. Imagine, for example, a surgeon who was granted no discretionary
power, and therefore had no freedom to deviate whatsoever from an excruciatingly
detailed plan to which a patient had consented prior to surgery. She would be unable to
change course mid-way through a surgery in light of unforeseeable circumstances. This
lack of freedom could have potentially devastating results for the patient’s health. Thus,
in order for the doctor-patient relationship to be effective, patients must allow their
doctors to wield at least some degree of discretionary power.
Second, the discretionary power that doctors wield is clearly power over patients’
significant practical interests. One’s overall welfare is highly dependent upon one’s
health since illness can make many other valuable goods difficult or impossible to obtain.
For instance, if illness seriously impairs one’s mobility or cognitive functioning, then it
can be challenging for one to pursue one’s considered life plans (since those plans may
include travelling around the world or attaining an advanced degree). One’s health
interests may therefore be amongst one’s most significant practical interests.
Third, this discretionary power is properly understood as authority. Recall that
fiduciaries have the authority to exercise legal capacities on their beneficiaries’ behalves.
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When doctors diagnose illnesses, recommend treatments, and perform medical
interventions, they are effectively exercising the legal capacity to make decisions relating
to their patients’ health and welfare on their patients’ behalves. Of course, a doctor’s
authority to exercise this capacity is not unlimited. As discussed above, doctors do not
have the authority to decide on a competent patient’s behalf what treatment option should
be pursued. That decision resides with the patient herself. However, patients do grant
doctors authority over other aspects of their health interests, including the power to
18

decide what medical information they should receive in order to choose a treatment.

In

addition, once a treatment option has been chosen, a doctor has the authority to carry out
the interventions involved in the treatment plan (which can include operating on the
patient, providing her with medications, and so on). Finally, since doctors are granted
power over their patients’ health interest in order to help their patients’ get better (or not
get sick in the first place), the power that doctors have over their patients’ health interests
is clearly purposive. In all, I conclude that doctors exercise discretionary authority to
pursue their patient’s significant practical interests. Therefore, the doctor-patient
relationship ought to be recognized as fiduciary.

18

This is the case with competent patients, at least. In the case of patients who cannot

provide consent, the doctor’s authority to act on the patient’s behalf may come from
either a proxy decision-maker or from the state
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1.3

Objections to the Doctor-Patient Relationship as

Fiduciary
The fiduciary understanding of the doctor-patient relationship is not immune to criticism.
In this section, I outline and respond to two of the most pressing concerns. The first is
that fiduciary relationships are necessarily paternalistic, and therefore the fiduciary model
of the doctor-patient relationship is at odds with the promotion of patient autonomy (the
paternalism objection). The second is that the doctor-patient relationship cannot be
genuinely fiduciary since doctors cannot act with sufficient loyalty to their patients (the
divided loyalties objection). I will address each of these worries in turn.

1.3.1

The Paternalism Objection

Acting paternalistically is often understood as interfering with another’s choices or
actions in a way that is against their will (or without their knowledge), but for the sake of
their own good (or at least, what the person doing the interfering believes is for their own
good) (Schramme 2015, 1). In the realm of bioethics, paternalism has long been a subject
of derision. Medical paternalism is often perceived as a byword for clinical conduct that
ignores patient autonomy. Endorsing a paternalistic view of the doctor-patient
relationship seems to place doctors in a dominant position over patients. It licenses
doctors to prioritize what they believe to be their patients’ needs over their patients’
rights, leaving patients acutely at their mercy (Beisecker and Beisecker 1993, 46). As
Susan Sherwin (1992) puts it, “Medical tradition has been to grant physicians license to
treat as they see fit, and physicians have long considered themselves authorized to
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proceed with whatever medical care they judge most appropriate; patient consent has
usually been treated as, at most, a formality” (137). Indeed, many view the desire to
move away from medical paternalism as one of the main drivers behind the development
of bioethics as a field (Schramme 2015, 1). According to Roger Dworkin (2003), “The
most ballyhooed achievement of the bioethics movement has been the triumph of patient
autonomy over medical paternalism” (235).
This disdain for medical paternalism presents a problem for the fiduciary model
of the doctor-patient relationship because the fiduciary relationship is, at least to some
degree, though to be a paternalistic relationship. Daniel Markovits (2014) explains that
fiduciary loyalty,
[B]uild[s] a measure of paternalism into every fiduciary relationship…. [E]ven
where paternalism is not specifically required or permitted by law, it remains
woven into the fabric of the fiduciary relation [because] the beneficiary has
sought precisely the fiduciary’s independent and (in commensurate measure)
unreviewable judgment, and thus also the paternalism that the exercise of this
judgment inevitably involves. (217)
In other words, there is something inherently paternalistic about a fiduciary’s exercise of
discretionary power. A fiduciary is obligated to use her own judgment about what course
of action is in the best interests of her beneficiary. If we should reject paternalism in the
doctor-patient relationship and if fiduciary relationships are inherently paternalistic, then
we should reject the view that the doctor-patient relationship is fiduciary.
The literature on the tensions between paternalism and autonomy is vast, and I
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won’t attempt here to resolve the debate once and for all. However, what I will suggest is
that the paternalism that is inherent in fiduciary relationships need not be the strong
medical paternalism of the past. Rather, fiduciary paternalism is more accurately
understood as a weaker form of paternalism, which may be manifested as ‘guided
paternalism’ (Chin 2002, Lim 2002) and through ‘nudging’ (Thaler and Sunstein 2008).
Guided paternalism is an approach that “sees the physician as [someone] who helps the
patient in value clarification and in processing the various potential interventions” (Chin
2002, 154). According to this view, doctors should aim not only to discuss with patients
what options they have, but also guide patients in determining what they should do based
on their own values and goals. This approach acknowledges that patients, who must
ultimately live with the consequences of medical treatment, should make the final
decisions. Yet, it carves out a role for doctors to exercise their discretion in helping
patients make the best choices for themselves. Guided paternalism, according to Chin
(2002), acknowledges that doctors’ efforts to promote a patient’s best interests should
include “facilitating and enhancing the latter’s capacity for self-determination, in
accordance to the patient’s own perspectives,” rather than acting against a patient’s will
(154).
A doctor’s fiduciary paternalism may manifest in what Richard Thaler and Cass
Sunstein (2008) call ‘nudges’, which are actions that steer someone in a certain direction,
but leave open the option for them to choose another course.19 Thaler and Sunstein claim
that nudges are not coercive since the individual being ‘nudged’ remains free to make her

19

See Leonard (2008) for a useful summary of their position.
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own final decisions. Nudges exploit the fact that the architecture of choice can make a big
difference in people’s decision-making. Something as simple as the order in which
information is disclosed or options are presented can have a large effect on what choices
individuals make. For instance, in order to promote healthy eating, a school cafeteria may
decide to place a salad bar at eye level and place junk food in harder to reach places
(Thaler and Sunstein 2008, 1). While students would not be prevented from eating junk
food, the arrangement of food makes it more likely that they will make healthier choices.
In the medical context, Thaler and Sunstein’s research on choice architecture
implies that it would be difficult for doctors to have no impact on their patients’ decisionmaking. After all, information has to be disclosed in some order. If a doctor wishes to
exercise her discretionary power in order to promote her patients’ interests, then it would
be wise to present choice options in a way that will guide her patients towards making
good decisions. The alternative to such ‘nudging’ would be to intentionally refrain from
presenting information in a way that would encourage an optimal outcome, which would
hardly be a triumph for patient autonomy.
Accepting that doctors may be justified in engaging in this form of paternalism
reflects the fact that patients typically seek out doctors precisely because they want to
benefit from doctors’ expert medical knowledge and skill. Doctors often do have a better
understanding of patients’ health interests, narrowly construed, than patients. Of course,
patients’ health interests are not the only relevant interests when making treatment
decisions. Patients will often have to weigh health-related concerns against other
concerns, such as religious or moral convictions or the effect that undergoing a particular
treatment may have on the pursuit of their life goals. A concert pianist, for instance,
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would have a difficult decision to make if faced with a choice between a highly effective
treatment for cancer that might cause peripheral neuropathy (which can lead to
difficulties in the fine motor skills required for playing the piano at a high level) and a
somewhat less effective treatment with side effects that wouldn’t inhibit her ability to
play the piano. Even though her medical interests would clearly be better served by
receiving the most effective treatment, she may still take into account the threat such a
treatment may pose to her other interests. Importantly, a paternalistic approach need not
seek to override or exclude such non-medical interests. It is unlikely that a doctor’s
guided paternalism or ‘nudge’ towards a particular treatment option would be strong
enough to hinder a patient from giving great weight to a religious conviction or important
life goal in her decision-making process.
It is true that even non-coercive paternalistic measures, like emphasizing the risks
of forgoing a treatment, do reduce the sheer number of choices a patient can make. For
instance, imagine that a doctor suspects that her patient is refusing to undergo
chemotherapy out of fear of the negative side effects (perhaps he seemed fixated on the
risk of hair loss and didn’t seem to engage with other risks or benefits of treatment). The
doctor, as a believer in guided paternalism, does not chide her patient, but rather requests
that he take a one-week cooling-off period to thoroughly consider the risks and benefits
of refusing treatment before making a final decision. She asks her patient to reflect on
how refusing treatment will affect his life, and tells him that she will be available
throughout the week to answer questions or to discuss things further. This approach does,
in effect, remove one of the patient’s options—namely, the option to immediately decline
chemotherapy (Aggarwal, Davies, and Sullivan 2014). However, simply having more
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options does not necessarily increase one’s autonomy. Being able to choose amongst
fewer options that have been curated by a medical professional who is obligated to
advance your interests can be more conducive to making a good decision for yourself
than receiving utterly comprehensive medical information with absolutely no guidance. I
therefore claim that fiduciary paternalism, manifested as guided paternalism or nudging,
is not a substantial threat to patient autonomy. A doctor can exercise discretion in
providing information and recommending treatment options with the goal of helping her
patients make the right decisions. Fiduciary powers can be exercised in a manner that
supports, rather than competes with, patient autonomy.
On the other hand, one may argue that nudging is not a truly paternalistic
intervention at all. Sherzod Abdukadirov, Scott King, and David Wille (2016), for
instance, have argued that although Thaler and Sunstein use the terms ‘nudge’ and
‘libertarian paternalism’ interchangeably, not all nudging is actually paternalistic (3).
They argue that nonpaternalistic nudges simply “seek to identify the sources of biased
behavior and to counter those biases through behavioral design” (Abdukadirov, King and
Wille 2016, 16). Such nudges are not paternalistic because “they do not rely on
identifying a specific optimal choice,” and thus do not attempt to push the ‘nudgee’ to
make the decision the ‘nudger’ thinks is best (ibid). One could make a similar argument
about guided paternalism in general; it may not truly be paternalistic since it does not
involve a doctor imposing decisions upon their patients against their will, but rather
assisting them in making their own decisions. If this is the case, then Markovits may
simply be wrong—there is nothing inherently paternalistic about fiduciary relationships.
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Ultimately, whether or not fiduciary relationships are necessarily paternalistic
hinges on how one understands paternalism. If paternalism always involves ignoring or
overriding a competent individual’s choices, then acting as a fiduciary need not—and
likely should not—involve paternalism. However, I have argued that paternalism can
consist in a fiduciary using the power she has been granted, as a professional with
specific expertise, to exercise control over her beneficiary’s interests in a way that is
sensitive to his considered values and goals, and helps him advance them more
effectively than he could on his own.
For instance, in the above example of the doctor who recommends that her patient
take a cooling-off period before making a final decision about declining chemotherapy
treatment, this doctor can be construed as imposing her judgments about what choice is
optimal upon her patient (albeit in a non-coercive way). Yet, she does this precisely
because she is justifiably concerned that her patient is basing his decision on a gut
reaction of fear, and has not fully thought through the implications of his decision. Her
hope is that through reflecting on his own values and life goals, he will realize that the
20

benefits of undergoing chemotherapy outweigh the risks.

She believes that

recommending a cooling-off period, although potentially limiting her patient’s liberty in
some respects, will actually help him make a decision that is truly in line with his
considered life plan. In this sense, the doctor’s exercise of fiduciary power is
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Of course, if after the cooling-off period, her patient still declines chemotherapy, then

the doctor would respect his decision.
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paternalistic, but it facilitates, rather than undermines, her patient’s autonomy.

1.3.2

The Divided Loyalties Objection

The second concern is that doctors may be unable to act as loyal fiduciaries in the
contemporary health care system. Marc Rodwin (1995) frames the problem as such:
Physicians have divided loyalties when they perform roles other than patient care
or serve two or more patients with diverging interests. In these circumstances,
pursuing legitimate roles may cause physicians to act in ways that are not in the
best interests of at least some of their patients. In some situations, the law has
even required physicians to act for the benefit of parties other than their patients.
Although these cases are exceptions, they nonetheless limit the context and
manner in which physicians can act as fiduciaries for patients. (251)
For instance, in cases of contagious disease outbreaks, doctors are sometimes charged
with protecting public health by disclosing the illness to authorities or quarantining the
patient. This can cause doctors to act in ways a fiduciary seemingly ought not to: by
breaking confidence or by acting against their patient’s desires. Moreover, in a world of
finite resources, doctors typically function as gatekeepers to medical resources. They
control the flow of services and access to specialists, and they may often make decisions
in their gatekeeper capacity that aren’t entirely consistent with promoting their patient’s
best interests, such as refusing to provide a patient with an expensive and only marginally
beneficial service in order to serve their hospital’s financial interests (Rodwin 1995, 252).
In such cases, it seems as though doctors are permitted, or perhaps even required, to serve
interests of parties other than their patients. Serving these interests puts strains on the
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fiduciary picture of the doctor-patient relationship, leading “us to ask whether doctors can
act as fiduciaries while acting on behalf of parties with different interests and whether it
is helpful to consider physicians as fiduciaries” (Rodwin 1995, 255).
Does the fact that doctors often have obligations to multiple parties mean they
cannot function as fiduciaries to their patients? Rodwin suggests not. He claims that there
is precedent for courts and legislatures to balance competing interests within a fiduciary
framework. Lawyers, for instance, are expected to act loyally in advocating for their
clients, while simultaneously functioning as officers of the court who must protect the
integrity of the judicial system (265). Similarly, parents, who are regarded as fiduciaries
in Canadian law (see M (K) v M (H) [1992] 3 SCR 6), will clearly have multiple loyalties
if they have more than one child. Rodwin suggests that it is only when a doctor’s
loyalties create “too great a conflict and there are no adequate ways to resolve these
conflicts” that a doctor’s multiple roles will present a problem for their ability to act as a
loyal fiduciary (256). In general, Rodwin claims that doctors can occupy fiduciary-like
roles vis-à-vis their patients, and also be able to take into account the interests of other
patients or parties.
Although I agree with Rodwin that the specter of divided loyalties does not
undermine the case for viewing the doctor-patient relationship as fiduciary, I do think
more needs to be said about what competing obligations are legitimate. Take, for
instance, the question of whether or not doctors ought to accept gifts from pharmaceutical
companies (Mehlman 2015, 45). How ought we to determine whether accepting such
gifts violates doctors’ fiduciary duty of loyalty? As Stephen Toulmin (1986) puts it, what
is needed is a way of clarifying when conflicts, or the potential for conflicts, within the
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fiduciary relationship “escalate into a larger question of divided loyalties or fiduciary
ambiguities” (783).
To answer this question, further examination of fiduciary loyalty is required.
Recall that the goal of fiduciary loyalty is primarily to protect the beneficiary from abuses
of discretionary power. There are two requirements of this duty: a positive obligation to
act in a beneficiary’s relevant interests, coupled with a prophylactic requirement that
fiduciaries avoid situations where they might be tempted to act otherwise (Smith 2003,
3). According to Lionel Smith (2003), these two elements are fundamentally connected to
the fiduciary’s motives. Smith argues that in the fiduciary context, “Disloyalty is a matter
of motive” (21). Smith explains that “the heart of the fiduciary obligation is the
surveillance and the justiciability of motive. Whatever powers a fiduciary has, he must
exercise them (or not exercise them) with a particular motive. He must act (or not act) in
what he perceives to be the best interests of the beneficiary” (14). Smith’s arguments
have a great deal of intuitive appeal. After all, if a fiduciary used her discretionary power
in a self-interested way, which by chance also happened to bring about an outcome that
was in her beneficiary’s interest, most would agree that the fiduciary was still abusing her
power. The fact that the action turned out to be in the beneficiary’s interests is not,
therefore, sufficient to conclude that the fiduciary acted loyally. Understanding fiduciary
loyalty as a matter of motive also deepens our understanding of the aforementioned
prophylactic requirement. Preventing fiduciaries from entering into situations where they
may have conflicts of interest can be viewed as a means of protecting their motives from
being compromised. Of course, fiduciaries’ actions can still be evaluated on the basis of
outcomes (for instance, outcomes are relevant when considering whether a fiduciary
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exercised due diligence). However, if a fiduciary fails to perform her role competently,
this is not in and of itself a violation of loyalty. A lawyer can be a terrible lawyer without
ever being disloyal.
The question then becomes: how do we evaluate a fiduciary’s motives? In
general, the (dis)loyalty of motives can be evaluated with reference to the reasons for
which the fiduciary powers in question were granted. When determining whether or not a
fiduciary acted loyally, one must look to whether or not she was attempting, in good
faith, to use her discretionary power to achieve the ends for which she was empowered in
the first place. This type of evaluation has some clear implications, such as the exclusion
of self-interested motives. If a fiduciary uses the powers she has been granted over
another’s interests with the goal of promoting her own interests, she is obviously failing
to act loyally. She wasn’t granted such powers so that she could profit. However, this
approach also has some more subtle implications that have to do with the complex
questions of loyalty that Rodwin discusses.
I argue that evaluating a doctor’s motives, when they stem not from self-interest
but rather an interest in protecting public health or effectively distributing limited medical
resources, for instance, requires that we understand the doctor’s professional role. In
terms of the doctor-patient relationship, it is often acknowledged that doctors have
professional obligations that go beyond their relationships with individual patients. The
medical profession is defined and justified not only by the relationship between doctors
and their patients, but also in terms of the importance of the profession’s societal function
(Kolers 2014). Regardless of whether one wholly endorses a ‘social contract’ view of the
relationship between the medical profession and society, it is difficult to deny that society
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has certain legitimate expectations of the profession vis-à-vis the public good. As Richard
Cruess and Sylvia Cruess (2004) put it, “Inasmuch as the profession is given a monopoly
over the practice of medicine, it is expected that its members will address the problems
faced by individual patients and also concern itself with issues of importance to society”
(2). For instance, it is widely agreed that the medical profession as a whole is obligated to
provide treatment to patients with communicable diseases, even if doing so places
21

doctors’ own health at risk (Daniels 1991, Hui 2005b).

Treating such patients is a

matter of public good, not just a concern for individual patients.
Given doctors’ social and professional role, I argue that it is legitimate for their
uses of discretionary power to sometimes be motivated, in part, by the larger obligations
they have to society qua medical professionals. This ought not to be viewed as disloyalty,
I claim, because patients do not just grant doctors’ power over their interests with the
goal of promoting their health. Patients also empower doctors to act in their interests
insofar as they are members of a society that has a collective interest in the public good.
In that sense, a highly contagious patient also has an interest in being quarantined, even
if, in the moment, she believes she has a greater interest in being allowed to travel
internationally. A similar argument could be made for other fiduciaries, such as lawyers
who, as aforementioned, function both as advocates for their clients and also as officers
of the court who uphold the principles of justice. This view coheres well with Frankel’s
(2011) claim that fiduciaries who provide professional services can have not only
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There is debate, however, regarding to what degree individual doctors must discharge

this duty (Freedman 1988).
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individuals or groups as beneficiaries, but also the public at large. Members of the
professions, she claims, can be rightfully expected to use their fiduciary powers to meet
society’s needs in addition to the needs of particular beneficiaries (Frankel 2011, 36).
While obligations to individual beneficiaries and the public may sometimes clash, I claim
that the duty of loyalty is not designed to rule out such conflicts. In public health crises,
doctors can grapple with the competing interests of their patients and society without
necessarily violating their fiduciary obligation of loyalty.
What fiduciary loyalty ought to rule out, however, is the consideration of interests
that do not stem from doctors’ professional roles qua doctors. These are not limited to
self-interested motivations. Doctors can have all sorts of altruistic motivations that do not
stem from their professional role, such as motivations to do with religious or political
beliefs. It would be just as inappropriate for a doctor to fail to inform a patient of
promising treatment options due to a religious belief as it would be for a doctor to fail to
inform a patient of promising treatment options since they would be very costly for the
doctor’s clinic. Indeed, understanding the goals and requirements of loyalty as such can
also provide doctors with a tool to resist forces that seek to undermine their ability to act
loyally to their patients (Mehlman 2015, 48). As Mehlman points out, entities such as
managed care plans and hospitals that place doctors in positions that require them to act
out of inappropriate motivations could be held liable for interfering with doctors’
fiduciary duties (2015, 63).
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1.4

Conclusion

In this chapter, I have defended the view that doctors’ obligations to their patients are
best understood as stemming from the fiduciary nature of the doctor-patient relationship.
Following P. B. Miller, I claimed that a fiduciary relationship is a relationship in which
one person exercises discretionary authority to set or pursue the significant practical
interests of another. I then argued that the doctor-patient relationship satisfies this
definition since doctors wield considerable discretionary power over the health interests
of patients. Finally, I addressed two concerns with the fiduciary characterization of the
doctor-patient relationship—the paternalism objection and the divided loyalties objection.
I argued that the fiduciary model, although perhaps paternalistic to a degree, need not
involve the problematic paternalism of old medicine. Finally, I claimed that doctors are
able to act loyally to their patients, so long as their exercise of discretionary power is not
motivated by concerns with self-interest or interests that do not stem from their role as
doctors.
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Chapter 2

2

The Doctor-Surrogate Relationship as Fiduciary

Although the ethics of surrogacy have been discussed for decades, the growth of the
global commercial surrogacy industry, coupled with high-profile scandals,22 has given
rise to heated public and academic debate in recent years. The ethical and legal analyses
of surrogacy have been rich and varied. Some have focused on criticizing the practice,
arguing that transnational surrogacy arrangements lead to the exploitation of
impoverished women in the global south (Panitch 2013a), or with the impermissible
commodification of women’s reproductive capacities (Anderson 2000). Others have
examined the motivations of contracting couples (Parks 2014), or have looked at the
negative effects that surrogacy has on children (Overall 2015). Some feminists have
rejected the practice entirely, viewing it as ‘baby-selling’ or as inherently demeaning to
women (Anderson 1990), while others have praised the potential for economic
empowerment and control over one’s body that surrogacy may accord to women (Teman

22

For instance, the case of baby Gammy, an infant with Down Syndrome born to a Thai

surrogate who was left behind by his Australian intended parents, garnered a great deal of
international attention (Saul 2014). I will discuss this case in greater detail in Chapter 4.
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2001). However, throughout these explorations of the ethics of surrogacy, comparatively
little attention has been paid to the moral status of a crucial actor: the fertility doctor.

23

Without doctors willing to provide prenatal and postnatal care to surrogates and
make use of assisted reproductive technologies (ARTs) for the purposes of surrogacy,
commercial surrogacy would cease to take place. However, participation in this industry
presents many ethical dilemmas for doctors. Typically, fertility doctors involved in
commercial surrogacy arrangements provide medical care for surrogates, but they are
hired by commissioning couples. The interests of the couple may not always align with
the interests of the surrogate, especially when it comes to decisions about multiple
pregnancy, birth defects, and selective reductions. Thus, the potential for conflicts is
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As aforementioned, there have been a few bioethicists who have considered this issue

(Rothenberg 1988, 1990; Ber 2000; Daar 2014; Rafique and DeCherney 2014). I explore
Rothenberg, Ber, and Daar’s views on doctors’ participation in surrogacy in Chapter 3. I
do not discuss Rafique and DeCherney’s article separately because they come to roughly
the same conclusion as Daar on the issue of non-consensual disclosure of information to
commissioning couples (although Rafique and Decherney’s case involves a doctor
entering information into the surrogate’s medical records rather than directly informing
the commissioning couple).
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great.24 How are doctors involved in surrogacy to navigate these situations?
In order to answer this question, it is important to understand what duties doctors
have when they participate in commercial surrogacy arrangements and why they have
them. In this chapter, I aim to provide a framework for conceptualizing these duties: the
25

framework of fiduciary obligation.

First, I will provide an account of the doctor-

surrogate relationship in practice, and give an initial explanation as to why the
relationship between fertility doctors and surrogates should be viewed as a doctor-patient
relationship. Given my arguments in Chapter 1 about the fiduciary nature of the doctorpatient relationship, I suggest that the doctor-surrogate relationship should therefore also
be viewed as normatively fiduciary. Then, I consider an objection to this view, the
difference position objection, which takes inspiration from the literature on medical
research ethics. The difference position objection states that since the aims and nature of
commercial surrogacy are distinct from the aims and nature of therapeutic medical
practice, the two realms ought to be governed by their own distinct ethical norms. The
fiduciary duties doctors have towards their patients, according to the objection, do not
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As I will discuss below, Chapter 3 is devoted to considering whether or not it is

actually possible for doctors involved in commercial surrogacy arrangements to avoid
conflicts of interest.
25

I provide a rough version of the argument for why the doctor-surrogate relationship is

fiduciary in Ryman and Fulfer (2017). However, the argument I provide here is much
more refined, and includes an explicit discussion of the duty of loyalty.
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necessarily apply to their relationship with commercial surrogates. To respond to this
objection, I argue that regardless of whether commercial surrogacy is sufficiently
analogous to therapeutic medical practice, the relationship between surrogates and the
doctors who treat them is nonetheless fiduciary. Given the discretionary authority that
doctors wield over surrogates’ significant practical interests, the doctor-surrogate
relationship satisfies the fiduciary principle I defended in Chapter 1, and doctors involved
in treating surrogates therefore owe them the duty of loyalty.

2.1 The Doctor-Surrogate Relationship
In this section, I explore the relationship between fertility doctors and commercial
gestational surrogates in practice, and explain why it is intuitive to view the doctorsurrogate relationship as a form of doctor-patient relationship. The roles fertility doctors
play in surrogacy vary depending on the circumstances in which surrogacy arrangements
take place. A country’s laws, health care regimes, and societal attitudes towards
surrogacy can shape the degree of involvement fertility doctors have in surrogacy
arrangements, and what legal and professional responsibilities they have. For instance, a
doctor who is employed at a surrogacy clinic in India will often be involved with
regulating and monitoring the diet, exercise, and general day-to-day activities of a
surrogate living in a surrogacy hostel (Pande 2014a). Such living arrangements grant
doctors a considerable level of access to and control over surrogates’ lives, which is rare
if not entirely absent in other surrogacy destinations like California (where surrogates
typically live in their own homes for the duration of their pregnancies).
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Nonetheless, despite variations in the particulars of surrogacy arrangements, I
argue that surrogacy inevitably involves the development of a doctor-patient relationship
between fertility doctors and the surrogates they treat. If it is true that the doctorsurrogate relationship is simply a type of doctor-patient relationship, then, like the doctorpatient relationship, it should be understood as being fiduciary. It is widely acknowledged
that a doctor-patient relationship is formed “when a physician affirmatively acts in a
patient’s case by examining, diagnosing, treating, or agreeing to do so” (Blake 2012, 404;
see also Bush 2010). Although a woman serving as a surrogate often does not require
medical diagnosis, she clearly undergoes examination and treatment.
The gestational surrogacy process is highly medicalized, and involves
considerable clinical interaction between doctors and surrogates. According to the
website for the organization “Surrogacy in Canada,” the gestational surrogacy process
can involve a range of treatments and interventions, including taking birth control pills or
hormone injections to coordinate cycles with the oocyte provider, undergoing embryo
transfer (which involves a reproductive endocrinologist inserting a speculum into the
vagina, inserting a catheter through the cervix and into the uterus, and then transferring
the embryos through the catheter into the uterus under ultrasound guidance), taking a
blood test to check for pregnancy, and having to take various fertility medications for 1014 weeks post-conception (“FAQ”, Surrogacy in Canada Online). Additional medical
procedures involved in the surrogacy process can include amniocentesis or chorionic villi
sampling to test for chromosomal abnormalities or fetal infections, selective fetal
reductions in cases of multiple pregnancy, or caesarian sections. Given that the doctorsurrogate relationship involves such examination and medical treatment, it seems to meet
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the conditions for the establishment of a doctor-patient relationship. Since, as I argued in
the previous chapter, the doctor-patient relationship is fiduciary, the doctor-surrogate
relationship should also be regarded as such. This means that doctors involved in treating
surrogates owe them the duty of loyalty, which includes the obligation to act in
surrogates’ best interests and to avoid conflicts of interest.

2.2 The Difference Position Objection
However, one may object that simply being examined and treated by a doctor is not
actually sufficient to make an individual a ‘patient.’ For instance, doctors examine
clinical trial participants and administer medical interventions in the context of research.
Yet, Howard Brody and Franklin G. Miller (2003) have argued that research subjects are
not patients, nor do they stand in traditional doctor-patient relationships with researchers.
26

Brody and F. G. Miller refer to this view as the difference position.

The difference

position holds that clinical research and therapeutic medical practice should each be
governed by their own set of ethical rules and principles. As Brody and F. G. Miller
(2003) put it, the difference position maintains:
[R]esearch and clinical practice are distinct activities with very different goals—
the former is intended to produce general medical knowledge to benefit future
patients, while the latter is aimed at producing a therapeutic benefit for the
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I also discuss Brody and F. G. Miller’s difference position in Ryman and Fulfer (2017),

but I do not apply it to the surrogacy context there.
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individual patient. Both research subjects and patients in the therapeutic setting
have basic rights that have to be respected, but one should not expect that the
same ethical principles necessarily would apply in both of these distinct settings.
(330)
Brody and F. G. Miller developed this view in response to what they call the similarity
position, which views medical research as normatively continuous with therapeutic
practice. The similarity position is mistaken, they claim, because it fails to recognize the
different underlying justifications for research and treatment, respectively. In the
therapeutic context, a doctor’s goal is to benefit her patients, who have typically sought
her help due to illness. When she makes medical judgments or provides treatments, she
does so primarily on behalf of individual patients. On the other hand, when it comes to
medical research, the doctor-researchers involved are not primarily acting on behalf of
their research subjects. Rather, researchers perform medical interventions upon subjects
primarily for the benefit of future patient populations. The good they hope to achieve is a
future good for society, not necessarily a good for one individual patient. According to
Brody and F. G. Miller, this distinction does not mean that researchers have no
obligations to subjects, but rather that the content and justification of their duties is
context dependent. For instance, they claim that in both research and treatment, doctors
have a duty to avoid causing harm. In the case of medical treatment, the doctors’
obligation to do no harm is derived from the duty of therapeutic beneficence they have
towards their patients. In the case of medical research, Brody and F. G. Miller argue that
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the obligation is derived from a duty of non-exploitation.27
This distinction, according to Brody and F. G. Miller, means that in the context of
research, doctors’ conduct need not be guided by duties they typically have towards
individuals whom they examine and treat, such as their fiduciary obligations. As they put
it,
One important ethical consequence of the difference position is that the
investigator, in contrast to the treating physician, cannot be seen as having a
fiduciary relationship with research subjects, including those who have a prior
physician-patient relationship with the investigator. In research, the investigator
cannot in good faith promise fidelity to doing what is best medically for the
patient-subject. It follows that to a greater or lesser extent the therapeutic
obligation of the treating physician must be suspended in the course of research.
(336, my emphasis)
In sum, even though research and treatment both involve doctors examining, diagnosing,
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Brody and F. G. Miller (2003) claim, “the harm-avoidance duty that the investigator

owes the subject is best understood as one of a number of duties that can be viewed
collectively as non-exploitation” (336). They argue that the duty of non-exploitation
requires investigators to ensure that the risks of trial participation are “minimized,
consistent with conducting scientifically valid research, and justified both by the potential
benefits to subjects (which may be lacking entirely) and by the potential value of the
knowledge to be gained from the research” (ibid).
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or treating individuals, the fact that doctors do so with ‘very different’ goals in mind
means, according to Brody and F. G. Miller, that they owe those who are being treated or
examined different obligations.
It is easy to see how this type of argument could be extended to the realm of
commercial surrogacy. Brody and F. G. Miller’s view is based in the principle that “the
clearest ethical thinking on an activity is obtained when one understands best the nature
and goals of that activity” (334). Applied to surrogacy, this would require that we
consider the nature and goals of commercial surrogacy when deliberating about the
ethical norms that should guide it. Just as Brody and F. G. Miller contrast the aims of
medical treatment with the aims of medical research, so too can we contrast the aims of
typical fertility treatment with the aims of commercial surrogacy.
When it comes to treatment for infertility, patients generally receive medical
interventions with the goal of overcoming infertility and enabling them to conceive and
birth healthy children. There is some debate as to whether or not infertility is a disease
(McTernan 2015; McLeod 2017). Moreover, even if infertility is a disease, IVF treatment
does not actually ‘cure’ infertility (Shannon 1987, 156-157). Nonetheless, most patients
seeking fertility treatment are suffering from a condition they hope to alleviate through
medical intervention. This may create a particular type of vulnerability and dependence
upon doctors, akin to the vulnerability caused by the “fact of illness” (Pellegrino 1979).
As Virginia Sharpe (1997) explains, illness is,
characterized by a sense of disruption, by anxiety, uncertainty and often fear and
pain that together force us to place ourselves under the power of another person—
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the health professional. The vulnerability that we experience as a result of illness
is thus compounded by the fact that the possibility of benefit depends on our
willingness to reveal our bodies, our personal lives and personal histories to
another. We must entrust to the health professional those things about which we
care most deeply. (202)
Regardless of whether infertility is truly an illness, it can lead to the type of vulnerability
that Sharpe describes. Anxiety, fear, and uncertainty about one’s ability to conceive
children is often what leads individuals to seek out fertility treatment, and thereby make
themselves dependent upon health care professionals (Cousineau and Domar 2007).
Thus, the relationship between doctors and patients in fertility medicine results from a
fundamentally therapeutic motivation: to alleviate the distress associated with infertility.
On the other hand, in the context of commercial surrogacy, women usually
receive medical interventions with the goals of obtaining financial compensation and
helping infertile individuals or couples form families. Unlike typical fertility patients,
surrogates do not seek out the help of fertility doctors in the hopes of ‘getting well.’
While surrogates are often vulnerable, due to poverty or lack of education for instance,
they may lack the particular kind of vulnerability Pellegrino and Sharpe regard as being
central to understanding the ethics of the doctor-patient relationship: that is, the
vulnerability caused by the ‘fact of illness.’ The relationship between surrogates and
fertility doctors is not initiated out of illness-related vulnerability, but rather out of a
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desire for financial gain.28 Indeed, there is a great deal of work on surrogacy that
advocates for viewing it more explicitly as a form of wage-earning labour, and for
granting surrogates various worker’s rights.29 The doctor-surrogate relationship may
therefore be understood as a commercial relationship that bears few morally relevant
similarities to the relationship that exists between doctors and patients in the context of
medical treatment.
Thus, a proponent of the difference position may conclude that commercial
surrogacy and fertility treatment should be treated as distinct realms of activity. The
doctor-surrogate relationship should be regulated by its own set of ethics and norms that
are independent of the ethics that govern doctor-patient relationships in fertility medicine.
It is beyond the scope of this chapter to fully flesh out what such a set of distinct norms
might include (especially since I will ultimately reject the difference position). Perhaps a
contractual approach, which treats doctors and surrogates as being bound only by the
terms of a mutually beneficial agreement, could be adopted. In any case, the logic of the
difference position implies that fertility doctors should suspend their typical therapeutic
obligations when treating commercial surrogates. They should perhaps function more as
technical specialists helping surrogates earn money for their reproductive labor, rather
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Altruism also often plays a motivational role in commercial surrogacy.
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See, for example, Cooper and Waldby 2014 or Pande 2014b. Katy Fulfer and I argue

that viewing surrogates as workers is not incompatible with also viewing them as
standing in fiduciary relationships with doctors (Ryman and Fulfer 2017).
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than as doctors providing care for patients.
One potential response to the difference position is that commercial surrogacy and
fertility treatment do share a crucial common goal, namely producing children for
infertile individuals or couples. Rather than being viewed as a distinct enterprise,
surrogacy should be understood as a form of medical intervention that is continuous with
in vitro fertilization (IVF)—the ‘next’ step in fertility treatment. This view would imply
that there is, in fact, a genuine doctor-patient fiduciary relationship that arises in the
context of commercial surrogacy: the relationship between the infertile individual or
couple and their fertility doctor. When she performs medical interventions on a surrogate,
the fertility doctor should therefore be seen as acting on behalf of the commissioning
couple (who are her true patients).
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According to this view, the nature and aims of

commercial surrogacy are not distinct from the nature and aims of fertility medicine, at
least when it comes to the relationship between fertility doctors and infertile individuals
or couples. Therefore, the two realms of practice should be governed by the same norms.
However, this response does not refute the logic of the difference position when
applied to the doctor-surrogate relationship. Although the goals of surrogacy and other
forms of infertility treatment may be the same from the perspective of the infertile
individual or couple, the nature of the relationships that arise between doctors and
surrogates may, according to the difference position, be much more like researcher-
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This view about doctors acting on behalf of commissioning couples while treating

surrogates is, as I will explain in Chapter 3, deeply problematic.
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subject relationships than doctor-patient relationships. In both cases, the doctors may be
seen as acting not on behalf of the individual they are ‘treating,’ but rather on behalf of a
third party (future patient populations or infertile couples, respectively). The difference
position objection could therefore retain its force when considering the norms that should
govern doctors’ obligations to surrogates.

2.3 The Fiduciary Relationship Between Fertility Doctors
and Surrogates
In this section, I respond to the difference position objection by arguing that the fiduciary
nature of the doctor-surrogate relationship does not depend on it being sufficiently similar
to the traditional doctor-patient relationship. Rather, the doctor-surrogate relationship is
normatively fiduciary due to the structure of the relationship, which involves fertility
doctors wielding discretionary power over surrogates’ significant practical interests. In
other words, I will argue that it does not matter if commercial surrogacy and fertility
medicine are distinct activities with different goals; the norms of fiduciary obligation still
apply in both areas of practice.
However, before I make this argument, I want to acknowledge that for some,
applying the difference position to the realm of surrogacy may read like a reductio. For
those who have the intuition that surrogates are clearly patients, a convincing analogy
between surrogates and human research subjects may constitute a reason to outright reject
the difference position (as it applies to both surrogacy and medical research). On the
other hand, those who find the difference position appealing in the realm of research but
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disagree with it in surrogacy may be able to argue that the two don’t stand and fall
together, and that there are morally relevant differences that render the analogy
inappropriate. I don’t intend to engage in such a debate here. My discussion of the
difference position is merely intended to give an account of why some might be skeptical
about viewing surrogates as patients.
To explain why the relationship between fertility doctors and surrogates is
fiduciary, I return to the analysis of the doctor-patient relationship I provided in Chapter
1. In that chapter, I defended Paul B. Miller’s definition of the fiduciary relationship as a
relationship wherein one party exercises discretionary authority to set or pursue the
significant practical interests of another. I then argued that the doctor-patient relationship
is fiduciary because doctors exercise discretionary authority to pursue the health interests
of their patients. To establish that the doctor-surrogate relationship is fiduciary, I adopt
the same approach. That is, I examine the doctor-surrogate relationship and determine
whether it involves doctors exercising discretionary authority over surrogates’ significant
practical interests.
This approach takes inspiration from P. B. Miller and Charles Weijer’s (2006a)
response to the difference position in the realm of medical research. P. B. Miller and
Weijer do not attempt to refute Brody and F. G. Miller’s claim that the goals and nature
of medical research differ from medical practice. Rather, they argue that researchers
wield considerable discretionary authority over the significant practical interests of
subjects, and that the researcher-subject relationship therefore satisfies the fiduciary
principle (P. B. Miller and Weijer 2006a, 430-431). P. B. Miller and Weijer do not hinge
the fiduciary status of the researcher-subject relationship upon it being sufficiently
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analogous to the doctor-patient relationship per se. They argue that it is fiduciary based
on the nature of the power wielded by researchers. I take up this tactic when responding
to the difference position view of the doctor-surrogate relationship. That is, instead of
attempting to argue away the differences between the goals and nature of fertility
medicine and those of surrogacy, I argue that the doctor-surrogate relationship
independently satisfies the fiduciary principle. This means that doctors cannot simply
suspend their fiduciary obligations to surrogates in the context of commercial
arrangements.
First, I will show how surrogates’ significant practical interests are at stake in
surrogacy arrangements. Then, I will illustrate how fertility doctors have discretionary
power over those interests. Finally, I will argue that the power that these doctors wield is
properly understood as the authority to act on surrogates’ behalves, relative to their
significant practical interests. In doing so, I will establish that even if commercial
surrogacy is importantly different from therapeutic medical practice, the relationships
that arise within it between doctors and surrogates are nonetheless fiduciary.
When engaged in commercial surrogacy, women’s significant practical interests
are clearly at stake. Like typical fertility patients, surrogates receive medical treatments
and tests that carry with them varying physical, psychological, and emotional risks. As
aforementioned, these procedures may include the injection of fertility hormones, the
transfer of embryos, abortion, or caesarian sections. Moreover, while pregnancy and
childbirth already pose risks—including eclampsia, gestational diabetes, and death—the
use of ARTs creates additional hazards. Fertility doctors often implant multiple embryos
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in surrogates to increase the success rate of pregnancy. Such practices can lead to either
multiple births, or to surrogates having to undergo selective fetal reductions, both of
which pose serious health risks (Tanderup et al. 2015a). There have even been reports of
surrogates dying as a result of birth complications (Carney 2010, ref. in Pande 2014, 15;
“Surrogate Mother Dies of Complications” 2012, ref. in Pande 2014, 15). Given these
serious risks, it would be difficult to deny that surrogates put their significant health
interests in the hands of their doctors.
Of course, the fact that surrogates’ significant practical interests are at stake does
not in and of itself mean that the doctors who treat them owe them fiduciary obligations.
Doctors must exercise discretionary authority over those interests in order for their
relationship to be considered fiduciary. I claim that when surrogates consent to
participate in surrogacy, they grant doctors discretionary power over their health
interests. Some of these powers are the same as those that exist in a traditional doctorpatient relationship, such as the power to diagnose illness and to gather medical histories.
However, some of these powers are more specific to the circumstances of surrogacy and
assisted reproduction. For instance, fertility doctors are often granted an enormous
amount of discretion in decisions surrounding the number of embryos to implant in a
surrogate, and whether or not to proceed with selective fetal reductions. Malene Tanderup
and colleagues’ study of Indian surrogacy clinics (2015a) revealed that decisions made
about the number of embryos to implant were almost always made by doctors alone.
Twelve of the clinics she studied had doctors who unilaterally made all of the decisions
about the number of embryos transferred, four clinics involved commissioning couples in
the decision-making, and only one clinic involved the doctor, commissioning couple, and
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surrogate (Tanderup et al. 2015a, 469). When it came to decisions about selective
reductions, only three clinics viewed fetal reduction as being a joint decision between the
doctor, commissioning couple, and surrogate, with other clinics treating it as a decision to
be made by doctors alone, or by doctors in conjunction with the commissioning couple.
Tanderup et al. also noted that surrogates were not always told the number of fetuses they
were carrying before undergoing fetal reduction (ibid).
Moreover, even in cases where surrogates are involved in the medical decisionmaking process, as they rightfully should be, they still must rely upon their doctors to
provide competent medical advice and treatment. This reliance is due to the fact that
surrogates typically lack the relevant medical expertise to evaluate their doctors’
recommendations and overall competency. Surrogates may, for instance, genuinely not
know whether they have the physical capacity to safely carry twins or triplets, and must
therefore rely on their doctors’ expert medical opinion. Surrogates’ reliance on doctors
may be particularly pronounced in situations where they are obligated to receive
preconception and/or early pregnancy care from doctors who are chosen by
commissioning couples since it may be difficult for them to seek out second opinions in
such cases.
Yet, is this discretionary power that fertility doctors wield properly understood as
authority? Recall P. B. Miller’s claim about what it means to have fiduciary power.
Fiduciary power does not consist in simply having the capacity to affect or influence
another’s interests. Rather, having fiduciary power means having the authority to act
relative to the significant practical interests of another in a substitutive exercise of a legal
capacity. For instance, returning to the personal trainer example from Chapter 1, although
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my trainer may have the power to affect my health interests (insofar as she can help me
exercise effectively or, conversely, cause me to injure myself), she does not have the
authority to act on my behalf when it comes to my health interests.
Do fertility doctors have this type of authority over surrogates’ interests? I claim
that they do. Recall that legal capacities include not only explicitly legalistic abilities, like
the ability to enter into a legally binding relationship, but also the capacity to make
decisions about one’s welfare. When women consent to serve as gestational surrogates,
they effectively empower the fertility doctors who treat them with the authority to
exercise on their behalf the capacity to make decisions about their health and well-being.
While surrogates can still consent to or refuse specific treatments (or at least, they ought
to be able to), doctors often exercise discretionary authority before treatment options are
even presented. Doctors make discretionary judgments in determining what tests or
treatment options are warranted, and what information should be supplied to surrogates in
the course of obtaining their consent.
A striking example of how doctors’ authority can operate comes from Elly
Teman’s work on surrogacy in Israel.
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She notes that in standard contracts in Israel,

surrogates are bound to comply with the medical recommendations of their doctors.
Although Israel’s patients’ rights laws technically protect surrogates (so that they cannot
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Surrogates in Israel can be paid for their services; however, there is not the same type

of commercial surrogacy industry in Israel as there is in the United States, for instance,
since surrogacy in Israel is run by the state. I thank Christine Overall for this point.
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be literally forced to obey their doctor’s recommendations), refusals are treated as
breaches of the surrogacy contract. As Teman (2010) explains, surrogates are therefore
“implicitly forced to comply because they would otherwise have to reimburse a couple
for all payments made until that point and to pay them an additional fine amounting to
thousands of shekels” (87-88). In circumstances like this, where it is difficult for
surrogates to refuse treatment recommendations, doctors’ authority over their interests is
especially pronounced.
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Yet, as discussed above, even in cases where surrogates are not

contractually committed to abiding by doctors’ judgments, they have still delegated the
powers to diagnose and recommend treatments to their doctors. While the scope of
doctors’ discretionary powers varies across different surrogacy contexts, in all cases
doctors clearly wield some degree of authority over surrogates’ significant practical
interests. Therefore, although surrogates typically do not experience the so-called
‘illness-related’ vulnerability that may result from experiencing infertility, they are
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Although there is no comprehensive data on how commonly this type of situation

occurs, the surrogacy contracts I’ve come across thus far have all included language
about surrogates being obligated to abide by the medical recommendations of the treating
doctor (who may be selected by the commissioning couple or a surrogacy agency hired
by the commissioning couple). I would venture that most commercial surrogacy
arrangements involve doctors having this type of pronounced power over surrogates’
interests.
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nonetheless highly vulnerable to doctors’ exercises of discretionary power.33
Finally, as with all fiduciary relationships, the power that doctors wield over
surrogates’ interests is clearly purposive. The aim of a surrogacy arrangement is to
produce a healthy child for a commissioning couple. Thus, surrogates give fertility
doctors power over their health interests in order to achieve this end. Indeed, a fertility
doctor would be misusing her fiduciary power if she did not act with this goal in mind.
However, the purpose of granting fertility doctors such power is also to protect the health
interests of the surrogate. Doctors are granted power over surrogates’ health interests
precisely because doctors have the knowledge and ability to safely perform the
procedures involved in surrogacy. In that sense, the relationship between surrogates and
their doctors is not all that different (or at least, it ought not to be that different) from the
relationship between a patient struggling with fertility and her reproductive
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P. B. Miller and Weijer make a similar point in their defense of the fiduciary

characterization of the doctor-subject relationship. They argue that although research
subjects are often vulnerable by virtue of being ill, this type of ‘circumstantial’
vulnerability is not relevant for determining whether they are owed fiduciary duties. They
argue that although vulnerability is a key characteristic of fiduciary relationships, it is the
structural vulnerability that arises from subjecting one's significant practical interests to
another’s exercise of discretionary power that matters (P. B. Miller and Weijer 2006a,
430). Illness-related vulnerability may be a relevant consideration for justifying other
obligations doctors have to their patients (for instance, perhaps they have duties
pertaining to good bedside manner), but these obligations are not fiduciary.
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endocrinologist. In both cases, there is a desire to bring a healthy infant into the world
and the need for medical intervention. In the latter case, a doctor would be acting
unethically if she allowed the goal of bringing a child into the world to override her
concern for protecting the health and well-being of the woman being treated. The same
should be true in the former case involving the surrogate. The goal of bringing a child
into the world should not trump the need for due concern about the health of the woman
doing the gestating, regardless of who will ultimately parent the child.
One interesting feature to note is that, on my account, the goals of commercial
surrogacy are important for considering what constitutes ethical conduct within the
doctor-surrogate relationship. In that sense, I agree with Brody and F. G. Miller; goals do
matter. However, we part ways when it comes to what goals matter for (that is, whether
the goals of a relationship can determine whether it is fiduciary). Recall that according to
a difference position view of surrogacy, the goals of commercial surrogacy are so
different from the goals of fertility medicine that doctors’ fiduciary duties can be
suspended in commercial surrogacy. However, I claim that the features of the relationship
itself (i.e. whether there is a delegation of power, whether one party is acting on behalf of
another, whether a party’s significant practical interests are in the hands of another, and
so on) are what matter for evaluating whether a relationship is normatively fiduciary.
Understanding the goals of the relationship is most important for determining what
constitutes appropriate exercise of fiduciary power. To evaluate a fiduciary’s use of
power, one must understand why she was granted those powers. In short, an examination
of the goals of a relationship matter more for evaluating a fiduciary’s conduct than they
do for determining whether a fiduciary relationship has been established in the first

71

place.34
In all, regardless of whether commercial surrogacy is morally continuous with
therapeutic medical practice, the doctor-surrogate relationship (like the doctor-patient
relationship) is normatively fiduciary. It involves one party (the fertility doctor)
exercising discretionary authority over the significant practical interests of another (the
surrogate). Therefore, doctors who treat surrogates owe them fiduciary obligations, as
discussed in Chapter 1. In particular, fertility doctors are obligated to uphold the fiduciary
duty of loyalty, which includes the duty to avoid conflicts of interest and the duty to
wield their discretionary power solely in pursuit of surrogates’ interests.
One may wonder, however, if it is actually possible for doctors to act loyally to
surrogates. At the end of section 2.2, I raised the possibility that the relationship between
a doctor and a commissioning couple may also be a fiduciary relationship. If a doctor
were in a fiduciary relationship with both a commissioning couple and also their
surrogate simultaneously, then this would likely generate a conflict of interest. In the
following chapter, I turn to this question of whether doctors can actually uphold their
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In general, when considering what obligations a particular relationship should involve,

it may be useful to draw a distinction between the goals of the relationship and its
normative structure. The goals of different types of fiduciary relationships are diverse,
but they fall under the category ‘fiduciary’ due to their shared normative structure.
Interpersonal trust relationships, for instance, may also function in this way. I thank
Dennis Klimchuk for this point.
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fiduciary duty of loyalty when involved in surrogacy arrangements. To put it in Brody
and F. G. Miller’s terms, I explore whether doctors can “in good faith promise fidelity to
doing what is best medically” for surrogates (2003, 336).

2.4 Conclusion
In this chapter, I argued that the relationship between surrogates and fertility doctors
ought to be regarded as fiduciary, regardless of whether or not one accepts the view that
all of the norms of the doctor-patient relationship should automatically apply to the
doctor-surrogate relationship. I began by outlining some features of the doctor-surrogate
relationship, and by suggesting that it is a form of a doctor-patient fiduciary relationship.
Then, I addressed an objection to this view, the difference position objection, which
claims that the doctor-surrogate relationship is morally distinct from the doctor-patient
relationship, and should therefore be governed by its own set of norms. I responded to
this objection by returning to the fiduciary framework I defended in Chapter 1, which
views relationships as fiduciary when one party exercises discretionary authority to set or
pursue the significant practical interests of another. I explained why the relationship
between doctors and surrogates satisfies this view of the fiduciary relationship. I
concluded that even if commercial surrogacy is distinct from therapeutic medical
practice, the relationship between doctors and surrogates (like the typical relationship
between doctors and their patients) is nonetheless fiduciary.
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Chapter 3

3

Conflicts of Interest, Divided Loyalties, and
Commercial Surrogacy

In the previous chapter, I argued that the doctor-surrogate relationship ought to be viewed
as a fiduciary relationship. Therefore, doctors owe surrogates the fiduciary duty of
loyalty, which comprises two aspects: the duty to use one’s discretionary power for the
sole benefit of one’s beneficiary, and the duty to avoid conflicts of interest. At the end of
Chapter 2, I raised the concern that doctors who treat surrogates may end up standing in
fiduciary relationships with surrogates and commissioning couples simultaneously. This
creates, I argue, a clear conflict of interest for doctors. In this chapter, I will address this
issue, as well as explicate other conflicts of interest that arise in commercial surrogacy.
Given that, as I will demonstrate, conflicts of interest abound in surrogacy, I question
whether it is possible for doctors to actually act loyally to surrogates. In other words, I
will address whether it is permissible for doctors to become involved in commercial
surrogacy arrangements.
I will begin by examining conflicts of interest in commercial surrogacy. As
previously discussed, the surrogacy industry is not monolithic; surrogacy practices vary
based on the laws and health care systems of the countries in which they take place.
While paid surrogacy is illegal in many places, such as Canada and Germany, it is a
profitable transnational industry in countries such as the United States (at least in some
states) and Ukraine. Up until recently, India, Thailand, Mexico, Nepal, and Cambodia
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were all attractive surrogacy destinations; however, these countries have restricted or
outright banned commercial surrogacy in the past few years (Srivastava 2017). In this
chapter, I will primarily draw from literature on surrogacy in India, Israel, and the United
States, including bioethical and ethnographic work and professional guidelines.
As I will explain, this literature reveals that there are many concerns with divided
loyalties in surrogacy practices. First, there are concerns that stem from conflicting
fiduciary obligations. For instance, in cases of ‘dual treatment’ (Daar 2014), a doctor is
put in a position where a commissioning woman and the surrogate she has hired are both
her patients, and acting in the best interests of one may mean failing to act in the best
interests of the other. Such cases typically occur when the commissioning woman is
contributing her own ova to the pregnancy. However, even in the absence of dual
treatment, conflicts of interest may still arise. A doctor who answers to, but is not
treating, a contracting couple may still find herself in a position where she feels obligated
to act in accordance with the couple’s wishes. Underlying these concerns are financial
conflicts of interest. Some feminists, like Karen Rothenberg (1990), have argued that
these pervasive conflicts of interest create seemingly insoluble moral dilemmas for health
care professionals. Thus, there is good reason to think that doctors should altogether
refrain from participating in surrogacy, lest they be put in a position where they will be
unable to uphold their duty of loyalty.
However, I will argue that these conflicts of interest are not intrinsic to surrogacy,
but rather a product of how commercial surrogacy arrangements tend to be undertaken. I
will propose some solutions to this problem of divided loyalties, drawing from the
literature on other ‘dual obligation’ contexts, including live organ donation and sports
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medicine. I will argue that doctors can ethically participate in surrogacy arrangements
only if these arrangements are structured to mitigate conflicting fiduciary duties and
financial conflicts of interest. First, in cases where commissioning couples bear the costs
associated with surrogates’ medical treatment, I argue that payments should be mediated
through surrogates rather than coming directly from commissioning couples. Second, I
claim that single embryo transfer should be made standard, so that there is no temptation
to bolster pregnancy success rates by implanting multiple embryos. Third, I argue that
surrogates must receive medical treatment from doctors who are independent from the
commissioning couple. I suggest that commissioning couples and surrogates should
therefore each have access to their own health care professional(s) who can assist them
throughout the process. This should be the case regardless of whether the commissioning
couple receives any medical treatment (i.e. whether or not they contribute their own
gametes). I recognize that adopting these recommendations may make commercial
surrogacy more uncertain for commissioning couples since their ability to control many
aspects of the surrogacy process will be restricted. However, I argue that such changes
are necessary so that doctors participating in commercial surrogacy arrangements can
honour their role as fiduciaries.

3.1 Conflicts of Interest in Commercial Surrogacy
In this section, I will explore in detail some conflicts that commonly arise in commercial
surrogacy arrangements, drawing from the bioethics literature, ethnographic work on
surrogacy, and professional guidelines. In medicine, a conflict of interest is sometimes
defined as a “set of circumstances that creates a risk that professional judgment or actions
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regarding a primary interest will be unduly influenced by a secondary interest” (Lo and
Field 2009, 46; ref. in Blake, McGowan and Levine 2015, 411). Conflicts of interest, in
other words, arise when a doctors’ professional judgment about a patient may be swayed
inappropriately by concerns external to their doctor-patient relationship. As discussed in
Chapter 1, not all influence of secondary interests rises to the level of a ‘conflict of
interest’ as defined by Lo and Field.35 Some consideration of secondary interests may be
unavoidable and may not end up posing a threat to doctors’ fiduciary loyalty. For
instance, if two procedures are equally effective, but one is less expensive, then a doctor
may legitimately perform the cheaper procedure for the sake of conserving medical
resources. In some sense, the secondary interest of limiting expenses influences the
doctor’s actions, but in a way that is still entirely consistent with prioritizing the best
interests of the patient. The interest in conserving resources is allowed to sway decisionmaking because both options available are equally favorable for the patient.36 Such a
circumstance does not, therefore, involve a conflict of interest. What is problematic is
when secondary interests unduly alter (or have the potential to unduly alter) a doctor’s
medical judgment such that her professional decisions are no longer motivated by a good
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In Chapter 1, I distinguished between ‘conflicts of interest’ and ‘divided loyalties;’

however, Lo and Field define conflicts of interest in a way that necessarily implies a
division of loyalty.
36

As I discussed in Chapter 1, Mehlman (2015) argues that taking seriously doctors’

fiduciary obligations can provide a tool for doctors to resist the commercialization of
medical practice if and when it undermines their ability to act loyally to their patients.
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faith desire to act in her patients’ best interests. This type of conflict, which involves an
inappropriate division of loyalty, will be the focus of this section.
The first conflict of interest I will discuss arises in the context of dual treatment.
Dual or simultaneous treatment occurs when the doctor who treats the commissioning
mother or couple is also the doctor involved in the medical treatment of the surrogate. In
her study of surrogacy in Israel, Elly Teman notes that dual treatment is common. She
explains that in most surrogacy contracts she examined, only one doctor was involved,
who accompanied “both the surrogate and the couple through the process and…
represent[ed] both parties’ interests” (Teman 2010, 89). Such arrangements create a clear
conflict of interest because the doctor has fiduciary obligations to two parties whose
interests may directly clash.
Consider the situation where a commissioning woman, Anna, is contributing her
own ova to the IVF process and is being treated by Dr. Brown. Dr. Brown is also the
doctor who ultimately performs the surrogate’s (Connie’s) embryo transfer, and treats
Connie throughout the IVF process. In this case, it is uncontroversial to claim that Anna
is Dr. Brown’s patient, and there is a fiduciary relationship between them. Anna is
receiving medical advice and treatment from Dr. Brown, who thereby wields
discretionary power over her health interests. Yet, as I argued in Chapter 2, the
relationship between Dr. Brown and Connie is also fiduciary.
The problem with such an arrangement is that often what is in Connie’s best
interests will not be in Anna’s best interests, and vice versa. For instance, imagine that
Anna had gone through multiple cycles of ovarian stimulation and egg retrieval that did
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not produce any viable eggs. However, her latest cycle was unexpectedly good,
producing three viable eggs that Dr. Brown was able to fertilize. Given the available
evidence, Dr. Brown is convinced that using multiple, rather than single, embryo transfer
37

in this case would increase the overall chances for a successful pregnancy.

However, as

mentioned in Chapter 2, having more than one embryo transferred at a time makes
multiple pregnancies more likely. As I will discuss in detail below, multiple pregnancies
pose considerable health risks to pregnant women, including preeclampsia and
postpartum hemorrhaging (Committee on Ethics 2007). In light of these risks, Dr. Brown
judges that it would not be in Connie’s health interests to undergo multiple embryo
transfer. In this case, it is unclear to whom Dr. Brown owes her allegiance. The best
decision for Anna is not the best decision for Connie. Yet, Dr. Brown appears to have a
fiduciary obligation to act in the best interests of both of them.
Due to the conflicts of interests that arise in dual treatment, the American College
of Obstetricians and Gynecologists (ACOG) strongly advises against such arrangements.
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Transferring multiple embryos at a time likely increases the odds of a successful

pregnancy per round; however, the clinical data on whether multiple embryo transfer
actually increases the overall rate of successful pregnancy is somewhat mixed
(Martikainen et al. 2001; Gerris 2009; Lee et al. 2016). The efficacy of transferring more
than one embryo at a time may also depend on the age of the woman receiving the
transfer (Lawlor and Nelson 2012). For the sake of this example, however, imagine that
Dr. Brown has done her due diligence in reviewing the available evidence, and is
convinced that multiple embryo transfer is the best option for Anna.
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ACOG’s Committee on Ethics’ “Opinion on Family Building Through Gestational
Surrogacy” states that:
Pertinent medical risks, benefits, and alternatives [to surrogacy] should be
discussed by the physicians treating the gestational carrier [sic] and intended
parent(s), and these physicians should be separate and independent, whenever
possible, to optimize patient advocacy and avoid conflicts of interest. (Committee
on Ethics 2016)
However, the ACOG guidelines only suggest that dual treatment should be avoided, and
ACOG has no authority to enforce a prohibition on dual treatment. Moreover, the ACOG
committee opinion also notes:
One generally unavoidable exception to this guideline [about having independent
fertility doctors] is the management of the preconception and early pregnancy
care of a gestational carrier [sic] by the same reproductive endocrinology and
infertility subspecialist who is treating the infertile intended parent(s). 38
(Committee on Ethics 2016)

38

This is a significant departure from ACOG’s 2008 Opinion on “Surrogate

Motherhood,” which was replaced by the 2016 Opinion. It stated:
A physician who performs artificial insemination or in vitro fertilization as a part
of surrogacy services necessarily will be involved with both the intended parents
and the surrogate mother. However the intended parents and the surrogate mother
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ACOG does not elaborate upon why this exception is generally unavoidable. One
possible explanation for this “unavoidability” is that, if fresh embryos are being used, it
might be necessary for the same doctor to treat both the commissioning woman (who is
contributing her own eggs) and the surrogate to facilitate embryo transfer. In fresh
embryo transfer, the surrogate and the commissioning woman’s menstrual cycles are
synced, which is typically achieved through the use of hormones. However, even if it is
easier to have one doctor overseeing this syncing process, it seems possible that it could
be done with two doctors in communication with each other. Another possible
explanation for the exception to the independence guideline is that some fertility
specialists may operate in regions where there are no other fertility specialists nearby,
which could make coordination challenging. In such cases, however, it would likely be
possible (though more expensive) for the commissioning woman to travel to another
clinic and have her eggs frozen for IVF use.39

should have independent counseling and independent legal representation, and the
surrogate mother should obtain obstetric care from a physician who is not
involved with the intended parents. (Committee on Ethics 2008, my emphasis)
The language of necessity has been removed in the 2016 Opinion, which suggests a
willingness to view dual treatment as less inevitable.
39

There is some evidence that the transfer of thawed frozen embryos produces a live

birth rate similar to that of fresh transfers (Wong et al. 2017).
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Despite ACOG’s determinations, there appears to be disagreement amongst
bioethicists as to whether doctors have an ethical imperative to avoid dual treatment.
Some, like Rosalie Ber (2000), support the sentiment expressed in ACOG’s guidelines.
She states,
[I]n order to avoid the issue of dual loyalty, it may be preferable that separate
physicians perform these roles/obligations [involved in surrogacy]. Thus, it is
possible to avoid coercing the surrogate mother to perform tests, or change her
style of living, continue with the pregnancy should she desire to terminate it, or
have the child delivered by Caesarian section to comply with the wishes of the
genetic parents of this “precious baby.” (157)
Ber is keenly aware that dual treatment leads to serious concerns about divided loyalties.
However, other bioethicists seem less troubled by dual treatment. For instance, although
Judith Daar (2014) acknowledges that professional organizations discourage dual
treatment arrangements, she seems to treat such arrangements as permissible when she
considers how doctors ought to navigate a surrogate’s hypothetical breach of contract.
Daar states that “dual treatment may be preferred when an intended mother undergoes
oocyte retrieval to contribute to the embryos transferred into the surrogate” (45).

40

She

considers doctors’ obligations in the context of dual treatment when they are faced with a
surrogate’s breach of contract. The scenario she imagines is one in which a reproductive
medicine specialist continues to treat both the commissioning couple and the surrogate
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Daar does not elaborate upon why dual treatment is preferred in such cases.
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until a pregnancy is well established, and this specialist discovers behavior that violates
the surrogacy contract.
Daar claims that doctors involved in surrogacy arrangements should familiarize
themselves with the conditions of the surrogacy contract so that they are aware of what
behaviours constitute a breach. She argues that if a contract calls for a surrogate to avoid
drinking alcohol or to only eat organic food for the duration of her pregnancy, the doctor
should assume that knowledge about behaviour that violates these provisions is material
to the commissioning couples’ decision-making about whether to proceed with the
surrogacy arrangement. As a result, Daar claims that a good contract will include an
agreement to waive confidentiality about any material information discovered by the
doctor in the course of treatment. Such waivers represent, according to Daar, “an
exception to a physician’s duty to maintain patient confidentiality” (2014, 46). If the
contract includes such a waiver, she recommends that doctors consider a two-part
approach, wherein they first encourage the surrogate to disclose the breach, and if the
surrogate refuses, the doctor can then discuss the breach with the commissioning couple
since it is “material to their ongoing informed consent” (ibid). In cases where the
surrogate has not expressly waived confidentiality in the contract, Daar recommends that
doctors should consider the pros and cons of nonconsensual disclosure. She ultimately
concludes that because a breach of the surrogacy contract could lead to the revocation of
the agreement, “the potential balance of harms seems to weigh in favor of disclosure”
(ibid). She grounds this recommendation in the duty to respect patient autonomy since it
includes, according to Daar, “the duty to provide information material to a patient’s
decision making” (ibid). Thus, in this type of conflict between her patients’ interests,
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Daar suggests that the doctor’s loyalty should ultimately lie with the commissioning
couple.

41

From the standpoint of fiduciary obligation, it should be clear that dual treatment
is a threat to a doctor’s duty of loyalty. If a doctor agrees to treat a commissioning
woman or couple, then she should refrain from initiating a doctor-patient relationship
with the surrogate they hire (except, perhaps, in a case where a surrogate requires
emergency medical treatment and no other doctor is available). Similarly, if a doctor
agrees to treat a woman acting as a surrogate, she should refrain from initiating a doctorpatient relationship with a commissioning couple (again, barring emergency scenarios).
Contra Daar, dual treatment is therefore never preferable, even if it is significantly more
convenient for the couple or doctors involved.42 The type of scenario Daar attempts to
address ought, from the fiduciary standpoint, never come about. The thought that the
conflict of interest in question can be resolved with a careful weighing of the potential

41

Daar’s argument also applies to dual treatment scenarios that involve a commissioning

couple disclosing a breach of contract to their doctor. (Imagine that a couple discloses to
their doctor that they are planning to divorce, which would violate a condition of their
surrogacy contract.) In such cases, the doctor could be justified in informing the surrogate
of the breach without the couple’s consent.
42

As I will discuss in section 3.2, alternative arrangements involving additional parties

who can facilitate the syncing of menstrual cycles are preferable in cases where the
commissioning woman is contributing her own gametes.
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harms and benefits of nonconsensual disclosure is wrongheaded. In this case, there is no
way to act in the best interests of both patients, and the conflict is therefore insoluble.
However, even if dual treatment is avoided, there are still other types of conflicts
of interest that arise in surrogacy. One may be concerned that even if the doctor treating a
surrogate is not also simultaneously treating the commissioning woman, she may
nonetheless be motivated by a consideration of the commissioning couple’s interests.
Rothenberg (1990) suggests this point in her critique of surrogacy. She states that, “By its
very definition, IVF and embryo transfer with a gestational surrogate is a case of
potential conflict of interest” (1990, 347); presumably, this is because there is always the
risk that the interests of the couple and the surrogate will clash. As aforementioned,
Rothenberg criticizes surrogacy arrangements in which the doctor treating the surrogate
plays any role in helping to enforce the terms of the surrogacy contract by disclosing
whether a surrogate smokes or drinks alcohol. Rothenberg claims that in their capacity as
‘monitor’ of the surrogate, doctors “take on the role of spy, rather than the fiduciary role
to the patient” (1990, 350, my emphasis).43 She also cautions that even if the surrogate is
treated as the sole decision-maker for her own medical care, in the event of multiple
pregnancy or birth defects, the commissioning couple and health care provider may still
exert pressure on her to make a decision in line with the couple’s desires, given that they
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As I discussed in the introduction, this is the only time Rothenberg mentions the term

‘fiduciary,’ so it is unclear what precise understanding of the fiduciary relationship she is
employing.
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will be parenting the future child. Rothenberg concludes that health care providers should
reject surrogacy as a solution to infertility, claiming that the “medical, ethical and legal
risks of using another woman to serve the interests of the infertile couple cannot be
minimized” (1990, 350).
Such concerns are supported by the study by Tanderup and colleagues on
decision-making in Indian surrogacy, which I discussed in Chapter 2. Tanderup et al.
(2015b) found that commissioning couples had a great deal of influence on doctors’
decisions, and were often treated as the ‘primary stakeholders’ in surrogacy
arrangements (493). This appears to be the case both when the commissioning couples
were directly consulted, and also when they were not consulted, but the doctor still
considered what they would want. Take, for instance, medical decision-making about
birth method. In three of the clinics Tanderup et al. studied, commissioning couples
were reported as exerting pressure on doctors to perform C-sections on surrogates
rather than allow for vaginal births. In one clinic, that pressure came in the form of
direct consultation; the commissioning couple could “reportedly directly decide the
mode and then pay the surrogate extra for the C-section” (2015b, 498). In the other two
clinics, the pressure was indirect as it resulted from what the doctors believed was in
the couple’s interests. One doctor claimed, “No one wants to risk a vaginal delivery
when it is such a wanted child… [and] These parents have been through so much, so we
don’t want to risk a stillbirth or other complications” (ibid).
Pande’s study also revealed that surrogates are often pressured into undergoing
medically unnecessary caesarian sections to satisfy the interests of commissioning
couples and to protect the ‘precious’ fetuses being gestated. Only two of the forty-two
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surrogates she interviewed had vaginal deliveries (Pande 2014b, 117).44 Pande attributes
the high prevalence of caesarian section births in part to the clinic staff’s desire to
accommodate their own scheduling needs and the scheduling needs of the commissioning
couple (particularly when the couple were international clients). She also suggests two
other possible causes: the staff’s belief that surrogates who give birth through caesarian
sections will be less attached to the babies than those who give birth vaginally, and the
desire to do everything possible to protect the ‘precious’ fetuses. One surrogate who was
interviewed about having to undergo a medically unnecessary caesarian section (referred
to by surrogates at the clinic as a ‘scissor’ operation) made this statement about the
surrogacy process:
It’s very painful—the medicines, the injections and now this scissor. It’s not like
there can’t be normal [vaginal] deliveries in this process but they [doctor and
intended parents] don’t want to take any risk. The child is most important, not our
bodies [emphasis added by Pande]. (Pande 2014b, 117)
Pande notes that the surrogate is “well aware of the doctor’s priority” since she
recognizes that the baby she is carrying for the commissioning couple is more ‘precious’
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According to the WHO, the ideal rate for caesarean section deliveries is between 10%

and 15% (WHO 2015). The caesarian section rate in general has been rising in India,
especially in private hospitals, with some regions reporting rates of 41-58% of deliveries
(Rao 2015). Yet, even when compared to the already high rates of caesarian section
deliveries in India, the 95% rate at the clinic Pande studied is striking.
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to the doctor than her own health (Pande 2014b, 118). It is worth noting that the doctor’s
desire to promote the health of the children being produced through surrogacy may also
give rise to a potential conflict of interest. I will address such considerations about
surrogates’ interests and children’s interests in Chapter 4.
Teman noted that in the cases she followed, the doctor was usually the primary
mediator of conflicts that occurred between the couple and the surrogate. One type of
conflict that arose in several cases surrounded what freedom surrogates had to travel
during pregnancy (on long bus or train trips, for instance). Teman explains,
In numerous cases, this issue was debated so heatedly by surrogate and couple
that it was only resolved by their doctor’s intervention. In two cases, the doctor
acceded to the intended mother’s pleas to recommend that the surrogate forfeit her
plans, and in two other cases, doctors acceded to the surrogate’s wishes and
reassured the intended mother that the surrogate would not endanger the
pregnancy by traveling. (2010, 89)
In these cases, the doctors clearly felt as though they had obligations to both the surrogate
and the commissioning couple, and their medical recommendations about what would or
would not endanger the pregnancy may have been shaped by where their loyalties lay.
Thus, even when there is no dual treatment, there is still considerable potential for
doctors’ medical judgment regarding their primary interest (the health interests of the
surrogate) to be unduly swayed by a secondary interest (the interests of the
commissioning couple).
Underlying this potential conflict of interest is, I argue, a considerable financial
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conflict of interest. Returning to the example of Anna, Dr. Brown and Connie, imagine
that Anna and her partner do not have access to public funding for fertility treatment, and
must therefore pay for all the medical expenses associated with the surrogacy
arrangement. In this case, there is a sense in which Dr. Brown is ‘working for’ Anna and
her partner. Dr. Brown may stand to benefit financially from making medical decisions
about Connie’s pregnancy that are in line with Anna and her partner’s interests, such as
scheduling a caesarian section on a date that is convenient for them or ordering invasive
tests such as amniocentesis to test for chromosomal abnormalities (when a C-section or
amnio would otherwise not be medically indicated).
Financial conflicts of interest arise most starkly in circumstances where the
fertility doctors involved in the care of surrogates are also fertility clinic owners. For
instance, Pande interviewed a doctor who served as both the chief doctor and proprietor
of a surrogacy clinic. Under such an arrangement, the doctor in question has significant
financial motive to prioritize the interests of the parties who are paying her (the
commissioning couples) over the parties she is treating (the surrogates). However, even
when doctors are not the owners of surrogacy businesses, financial conflicts can still arise
if they profit from making medical decisions that are not in surrogates’ best medical
interests. As mentioned in the introduction, there is an active transnational market for
surrogacy services, and pregnancy success rates can be used as a key marketing tool for
clinics to attract clients. According to Vanessa Gruben (2013), “High pregnancy rates…
translate into more business for the clinic, which is in the pecuniary interest of the
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physician” (270).

Although Gruben is discussing the competitive market in ova, her

point is equally applicable to commercial surrogacy. In the case of oocyte provision,
fertility doctors can be financially motivated to over-stimulate egg providers to maximize
the number of embryos that can be created. Similarly, surrogacy doctors can be
financially motivated to transfer multiple embryos at a time into surrogates to maximize
pregnancy rates. This is not just because they wish to expedite the process for
commissioning couples, but also because it can help attract future business to the clinic.46
For instance, Pande references promotional material from the Indian surrogacy agency
Rotunda Center for Human Reproduction, which claims, “Our pregnancy rates are very
high, because we can transfer more embryos in difficult patients (unlike clinics in UK
and Australia, where the number of embryos which can be transferred is limited by law)”
(“The Rotunda Overseas IVF Patient (ROIP) Program,” Rotunda Center for Human
Reproduction, ref. in Pande 2014b, 11). In the surrogacy clinics that Tanderup et al.
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Similarly, Jennifer Rosato (2004) argues that given the business structure of the

fertility industry in general, “there is intense pressure on doctors to maximize their
success rates” (73).
46

Increasing business is clearly beneficial for clinic-owners, but it is also valuable to

individual doctors since they still profit from increased business to the clinic. Moreover,
if a doctor develops a reputation for successfully facilitating surrogate pregnancies, this
may lead to her particular services being in high demand. Thus, such considerations can
still present financial conflicts of interest for doctors even if they do not own clinics
themselves.
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(2015a) studied, the maximum number of embryos doctors would transfer at a time
ranged from two to seven (469).
As aforementioned, in addition to improving pregnancy success rates, implanting
multiple embryos in surrogates often leads to multiple pregnancies. Multiple pregnancies
pose serious health risks to surrogates since surrogates must either undergo selective fetal
reductions or else carry multiple fetuses to term. The fetal reduction procedure itself
poses some risk of maternal complications, and can result in the loss of the entire
pregnancy (Brambati et al. 2004). Moreover, undergoing fetal reductions can be stressful
and emotionally painful, and can leave women with feelings of guilt and sadness (Garel
et al. 1997). On the other hand, as I previously discussed, carrying multiple fetuses to
term poses many health risks. According to the ACOG Committee on Ethics’ “Opinion
on Multifetal Pregnancy Reduction,” the maternal risks of multifetal pregnancies
“include hypertension, preeclampsia, gestational diabetes, and postpartum hemorrhage”
(Committee on Ethics 2007). It is questionable, then, whether implanting multiple
embryos is ever in the surrogate’s best medical interests. Yet, doctors are incentivized to
do just that since high pregnancy rates both satisfy their clients, and can also bolster the
clinic’s reputation and translate into more business in the future. Moreover, concern for
the financial interests of the clinic can also influence doctors in their decisions about
selective reductions. One doctor Tanderup et al. (2015a) interviewed explained, “We do
fetal reduction down to twins. It doesn’t look good for the clinic if we have too many
multiple pregnancies” (469). In general, the fact that doctors involved in commercial
surrogacy often profit from engaging in medical practices that are inconsistent with
surrogates’ best medical interests raises serious concern about their fiduciary loyalty.
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Even when doctors are, in practice, successful in prioritizing surrogates’ health interests
over their own profits, the specter of financial conflicts of interest may still loom.

3.2 Conflicts of Interest and Divided Loyalties: Meeting the
Challenge
Given the conflicts of interest that appear to permeate commercial surrogacy
arrangements, it may be tempting to conclude, as Rothenberg does, that doctors simply
should not participate in them. Even in the absence of dual treatment, there seems to be
the continual risk that doctors’ exercise of discretionary power within surrogacy
arrangements will be motivated by a commitment to promoting the interests of
commissioning couples and/or their own financial interests. Since fiduciaries are
obligated to avoid conflicts of interest, doctors should therefore avoid commercial
surrogacy arrangements.
However, I argue in this section that this conclusion is too hasty. I claim that,
contra Rothenberg, it is possible for doctors to uphold their duty of loyalty within
47

surrogacy arrangements.

47

I argue that the conflicts of interest that abound in surrogacy

In the next chapter, I will consider a final potential conflict of interest for fertility

doctors, namely between a surrogates’ interests and the interests of the child she gestates.
Rafique and DeCherney (2014), for instance, claim that “[a]long with her obligation to
[the surrogate], [the fertility doctor] has a responsibility to the unborn child” (12). I
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are not inherent to the enterprise, but are rather a result of poorly constructed and
regulated practices. Surrogacy arrangements must, I claim, undergo significant revisions
in order to render doctors’ participation in them permissible. To make this argument, I
first examine how conflicts of interest have been addressed in two other ‘dual obligation’
clinical contexts: sports medicine and live organ donation. Drawing upon insights from
those contexts, I then make several recommendations that, if put into effect, would help
mitigate conflicts of interest and ultimately enable doctors to act as loyal fiduciaries to
surrogates.
As discussed in Chapter 1, divided loyalties are a perennial concern in many areas
of medicine. It is helpful to examine these areas to understand what strategies can be
taken to mitigate the undue influence of secondary interests. One area of medical practice
where conflicts of interest give rise to ethical concern is sports medicine. In professional
sports, teams often hire their own doctors to care for and treat their injured athletes. Brad
Partridge (2014) points out that this state of affairs creates the potential for divided
loyalties. He frames the problem as such:
Team doctors clearly have an obligation to the welfare of their patient (the injured
athlete) but they also have an obligation to their employer (the team), whose
primary interest is typically success through winning. At times, a team’s interest

devote a separate chapter to this issue because it is a potential problem for all forms of
assisted reproduction, and therefore transcends the surrogacy context.
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in winning may not accord with the welfare of an injured player, particularly
when it comes to decisions about returning to play after injury. (65)
In other words, when doctors work for a sports team, there is the constant risk that their
medical judgments about players’ health will be clouded by a concern for the team’s
success. Moreover, they may be concerned that their very jobs rest on performing their
duties in a way that satisfies their employer’s interest in winning. In response to this
conflict of interest, Arthur Caplan (2014) argues that sports teams should not be
permitted to hire their own doctors. Rather, leagues should hire doctors for a professional
franchise, and those doctors should report to a head medical official or regulatory body.
In this way, doctors would be primarily accountable to the athletes they treat, and their
decision-making would be evaluated only by other medical professionals, rather than by
the owners or coaches of particular teams. Since doctors’ jobs would not be in peril if
they made decisions that were not satisfactory to the team, they can focus on making
decisions that are in the best interests of the athletes they treat.
Doctors working for sports teams are analogous to doctors involved in
commercial surrogacy arrangements insofar as they may be unduly influenced by both
financial interests and also third party interests (the team and the commissioning couple,
respectively) to make decisions that are not in their patients’ best medical interests. Part
of Caplan’s solution to this conflict in sports medicine is to create financial distance
between the team and the doctor. Such a strategy can also be applied to commercial
surrogacy arrangements. Surrogacy arrangements could be structured such that doctors
who treat surrogates would never be paid directly by commissioning couples. When
surrogacy arrangements take place within health care systems that require commissioning
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couples to bear the costs associated with surrogates’ medical treatment, payments for
these costs should not be made directly by the couple. Rather, payment should be
mediated through the surrogate. The commissioning couple could set up an account for
the surrogate, for instance, so that she could directly select her own doctor and pay for
medical treatments herself. That way, the doctors treating surrogates would genuinely be
‘working for’ the surrogates themselves, reducing the financial conflict that would
otherwise exist.
As I mentioned in the previous section, financial conflicts can also arise out of
doctors’ concern with their clinics’ reputation for high success rates. Having payments
come directly from surrogates would not necessarily help mitigate such a conflict. A
tactic for addressing this type of financial conflict of interest would be to impose uniform
standards of care across all surrogacy clinics. For instance, if single embryo transfer were
the enforced standard of care,48 then there would be no room for competition between
clinics surrounding boosting success rates by transferring multiple embryos. In turn, this
would limit the number of multiple pregnancies, and therefore limit the need for selective
reductions. This standard could be incorporated into surrogacy contracts, imposed by
legislation, or perhaps enforced by professional organizations (such as regulatory
colleges).49 Such considerations about financial conflicts of interest also suggest that

48

Any departure from that standard should be permitted only in circumstances when it is

clearly medically indicated.
49

I will address concerns with the enforceability of these limitations below.
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medical professionals who own surrogacy clinics should perhaps not be directly involved
in medical decision-making, so that no doctor-patient fiduciary relationship is formed
between clinic owners and surrogates. The potential for the undue influence of financial
motives may simply be too great.
Moving on from the insights gleaned from the ethics of sports medicine, another
area of medical practice where there are serious concerns with divided loyalty is live
organ donation. Since live organ donation involves doctors subjecting otherwise healthy
individuals to serious medical risks for the benefit of another, there is a great deal of
worry about potential conflicts of interest. The primary juncture in which conflicts of
interest arise in live organ transplantation is during the screening process that determines
if a prospective donor is an appropriate candidate. As Gruben explains, the concern in
live organ donation “is that the physician will be committed to the recipient’s transplant
and, as a result, may under-evaluate the prospective donor’s fear of donation or may
‘gloss over’ the risks associated with the donation” (Gruben 2013, 268). For instance, in
2010, a live liver lobe donor named Paul Hawks died during transplantation surgery
(Kowalczyk 2014). His widow, Lorraine, later discovered that he was approved to be a
donor despite doctors having found extra blood vessels in his liver (which can make
surgery more challenging), abnormalities in his electrocardiogram, and that he was near
the upper age limit for live donors. Moreover, the donor advocate working with him was
a part of the recipient’s (her brother-in-law’s) transplant team. Lorraine later sued the
hospital for malpractice, although it had been cleared of wrongdoing by a government
investigation. In a newspaper article chronicling the incident, a reporter noted that
Lorraine wondered “whether the transplant team, intent on saving her brother-in-law,
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Timothy Wilson, failed to focus enough on her husband’s safety” (Kowalczyk 2014).
In response to concerns about conflicts of interest, various guidelines have been
developed to ensure that the well-being of organ donors is protected. The American
Medical Association’s (AMA) Code of Medical Ethics’ “Opinion on Organ
Transplantation,” for instance, recommends that every donor be assigned an advocate
team that is as independent as possible from the team responsible for the recipient’s care.
The Opinion states:
Because donors are initially healthy and then are exposed to potential harms, they
require special safeguards. Accordingly, every donor should be assigned an
advocate team that includes a physician. This team is primarily concerned with
the well-being of the donor. Though some individuals on the donor advocate team
may participate in the care of the recipient, this team ideally should be as
independent as possible from those caring for the recipient. This can help avoid
actual or perceived conflicts of interest between donors and recipients. (AMA
Code of Medical Ethics’ Opinion on Organ Transplantation 2013, 205.)
The Multi-Organ Transplant Program of the University Health Network (UHN) in
Toronto has also developed ethical guidelines for live organ donation. When it comes to
donor evaluation, the UHN recommends that “separate health care teams assess potential
living donors and recipients,” and that each party should have their own doctor to
advocate for their interests (Wright et al. 2004, 410). They also recommend the use of
“separate coordinators, social workers and psychiatry staff whenever possible” in order to
“avoid conflicts of interest and permit advocacy for the potential donor while suitability
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is being determined” (ibid).
These guidelines suggest that in order for live organ donation to proceed in an
ethically sound manner, there must be as much separation as possible between the health
care professionals who evaluate and treat live donors and the health care professionals
who treat recipients. Moreover, an independent advocate whose sole role is to protect the
welfare of the donor must be involved. In these guidelines, there is less explicit
discussion about potential conflicts during transplantation surgery than there is about
potential conflicts during screening. However, the need for as much independence as
possible between the two health care teams is presumably relevant not just during
screening, but also during any medical interventions.
Live organ transplantation offers a useful comparison to surrogacy since both
involve health care professionals performing medical procedures that pose serious health
risks to otherwise healthy individuals for the benefit of a third party (although the risks of
live organ donation are greater).

50

In both surrogacy and live organ donation, there is a

pressing need to ensure that surrogates and donors are agreeing to take such risks freely,
and that they are physically and psychologically appropriate candidates. Of course, there
are many relevant differences. Live organ donations are intended to save lives, which is
why doctors are willing to put healthy donors at risk. Surrogacy does not save, but rather
creates, lives. There also appears to be a greater concern regarding conflicts of interest
after candidate approval in surrogacy than in organ donation. For one thing, surrogacy is
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Ber also considers the analogy between surrogacy and organ donation (2000, 162-163).
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a much lengthier process than organ donation, leaving surrogates under medical care for
longer than typical organ donors and giving rise to more opportunities for conflicts (about
genetic tests, birth method, fetal reduction, and so on).51 Nonetheless, despite these
differences, the ethics of live organ donation present a useful touchstone when tackling
conflicts of interest in surrogacy.
In section 3.1, I discussed the current ACOG guidelines on surrogacy, which
recommend that the doctors treating the surrogate and the commissioning couple should
be separate and independent, except in cases where the surrogate’s preconception and
early pregnancy care is done by the same doctor who is treating the commissioning
couple. Although this guideline is partially correct insofar as it recognizes the desirability
of separate treatment, it does not go far enough. As I argued above, it is not sufficient to
simply avoid situations where the same doctor treats both the commissioning couple and
the surrogate (and the ACOG guideline doesn’t even wholly proscribe such
arrangements). This is because there remains the potential for the doctor treating the
surrogate to nonetheless feel obligated to the commissioning couple or be otherwise
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After an organ donor has been approved, she typically undergoes surgery and a

recovery period, spending roughly two days in hospital and four to six weeks recovering
at home (“What to Expect as a Living Donor,” Johns Hopkins Comprehensive Transplant
Center, 2016). On the other hand, surrogacy can occupy over a year of a woman’s life,
factoring in the time it takes to receive hormone treatments, gestate, give birth, and
recover.
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influenced by their desires. The ACOG guidelines fail to address the conflicts of interest
that may arise even in the absence of dual treatment.
Drawing inspiration from live organ donation guidelines, I argue that separate
advocate teams should attend to surrogates and commissioning couples, respectively.
These teams may include psychologists, social workers, fertility doctors, and
obstetricians who are able to guide their respective client/patients through the process and
advocate for their interests. If coordination needs to occur in the preconception or early
pregnancy stage (for example, if menstrual cycle syncing needs to occur for the transfer
of fresh embryos), this can be achieved by using a coordinator, rather than by simply
having one doctor treat both parties. In cases where neither member of the
commissioning couple is contributing their own gametes, it may be unnecessary to assign
a full team to them. Nonetheless, the commissioning couple should never interact directly
with the professionals caring for the surrogate since this presents the opportunity for the
couple’s interest to unduly influence the doctors’ actions. As the Tanderup study
revealed, even if couples are not explicitly consulted about their preferences for the
surrogate’s treatment, a concern for what they would want can still influence doctors’
judgments if there is insufficient separation from the couple. It is therefore still advisable
to have an independent doctor or coordinator who can update the couple and provide
them with whatever medically relevant information the surrogate has consented to share.
An implication of this recommendation is that commissioning couples would have
no direct say in the medical decisions being made throughout the course of the
surrogate’s pregnancy. In particular, this means that couples would not be able to make
medical decisions regarding genetic testing, abortion, or selective fetal reductions
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(although, as per my earlier recommendation, multiple pregnancies would be much less
common if a standard of single embryo transfer is adopted). To some, this may seem like
an objectionable state of affairs since the commissioning couple has a strong interest in
determining whether the child they will parent will suffer from a genetic disease or how
many of ‘their’ children will be born.52
My response to this concern comes in two parts. The first part of my response is
that commissioning couples would still have some degree of input through their
agreements with surrogates. A surrogacy contract can still specify that a surrogate will
agree to request certain tests, disclose their results, and ultimately abort the pregnancy if
certain genetic defects are found. There is nothing in my recommendations that prevents
the surrogate and commissioning couple from discussing the pregnancy with their legal
representatives and making decisions amongst themselves. However, any agreement
made between a surrogate and a commissioning couple should not bind doctors’ clinical
judgments or practice. For instance, returning to my previous example of Anna and
Connie, imagine that their arrangement has been constructed according to my guidelines,
and that Dr. Brown is the primary doctor treating Connie. Anna and Connie have agreed
that Connie will request amniocentesis. Yet, when Connie requests the procedure, Dr.
Brown informs her that there is no clinical indication that amniocentesis is warranted. Dr.

52

This also poses a risk that more children will be born than the commissioning couple

are willing to parent, which may put the future children’s interests at risk. As
aforementioned, I will discuss doctors’ obligations to children in more detail in Chapter
4.
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Brown, as a diligent practitioner, also informs her thoroughly about the risks and benefits
of the test. If Connie, after being fully informed about amniocentesis, still wishes to have
it done, then Dr. Brown can certainly perform the test. However, if after being informed
about the risks of the procedure, she no longer wishes to undergo it, then that should be
the end of the discussion. Dr. Brown would be under no obligation to perform
amniocentesis just because Anna and her partner want certain information. Contra Daar, I
argue that Dr. Brown should not even be aware of the details of what Connie has agreed
to unless Connie herself informs Dr. Brown of these details. In general, a doctor should
never be in the business of enforcing the terms of a surrogacy contract. This means that
contracts wherein surrogates waive their right to doctor-patient confidentiality in advance
are unacceptable, and a doctor should not agree to be party to such an arrangement.
Although my recommendation doesn’t preclude the commissioning couple from
having any input, it still does leave considerable uncertainty for the commissioning
couple. This leads to the second part of my response: family formation is often
complicated and there are many aspects of the process that cannot be controlled. This is
true in adoptions, and also to some extent in unassisted reproduction. It is therefore not
unreasonable to expect commissioning couples to be willing to tolerate a degree of
uncertainty. Just because surrogacy presents commissioning couples with the possibility
to assert control over certain outcomes does not mean that they should. While
commissioning couples’ interest in determining how many children they will be expected
to parent or whether a pregnancy should continue at all is certainly important, it is not
overriding. Surrogacy arrangements should be undertaken with the express
acknowledgement that medical decisions will ultimately reside with the surrogate, and
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that couples’ input into such decisions will occur at the surrogate’s discretion. Only under
these circumstances can doctors truly act loyally to surrogates.
These recommendations—that doctors not be paid directly by commissioning
couples, that single embryo transfer be adopted as the standard, and that commissioning
couples and surrogates be attended to by their own independent health care professionals
or teams—may make commercial surrogacy function much more like an adoption that is
arranged before birth than it currently does, at least from the perspective of the doctors
involved in the surrogate’s care.53 Although there is an understanding that the woman
who gestates the baby will not be the individual who parents him/her, this fact should
have no impact on the medical treatment of the woman doing the gestating. From the
doctor’s point of view, the primary difference between an adoption arrangement and a
surrogacy arrangement would simply be the use of IVF in conception.
The notion that surrogacy arrangements could function as a type of adoption is
not new; it has been around at least since Bonnie Steinbock’s 1988 paper, “Surrogate
Motherhood as Prenatal Adoption.” Steinbock suggests that surrogacies could proceed
much like adoption arrangements made before a child’s birth (‘prenatal’ adoptions). To
the best of my knowledge, prenatal adoption does not legally exist in any jurisdiction
since adoption papers cannot be signed before the child in question is born. However,
adoption arrangements can indeed be worked out in advance of birth, such that the
adoptive couple and the birth mother have a mutual understanding that the adoptive
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I thank Amalia Amaya for this point.
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couple will parent the baby. (The birth mother is free, however, to opt out of this
agreement if she decides she wants to parent the infant.) In such arrangements, the
prospective parents may be involved in the pregnancy to some degree. As Steinbock
notes, the prospective adoptive parents may even be present for the child’s birth (1988,
43). Moreover, prospective adoptive parents may pay for the birth mother’s medical
expenses, or even for things like food, rent, or maternity clothes when doing so is
consistent with adoption laws (Thalken 2013). However, since in these arrangements, the
adoption does not legally take place until after birth, the birth mother should still be
treated as the decision-making party. For instance, the birth mother is the one who
ultimately makes decisions about birth method, genetic testing, or abortion in the event of
birth defects. Although the birth mother may certainly consult the adoptive parents if the
decisions may impact their decision to adopt, it would be entirely inappropriate for her
doctor to engage in such consultation.
As far as the doctors who treat the surrogate are concerned, surrogacy
arrangements could function much like these so-called ‘prenatal’ adoption arrangements,
with the additional presence of IVF use in conception. Some jurisdictions have begun
moving towards a more adoption-like model for surrogacy regulation. Ontario, for
instance, passed legislation in November 2016 called the All Families are Equal Act,
whose surrogacy regulations are “based on a model more akin to adoption than third
party reproduction” (Cohen 2016). I should note that I am not arguing that this Act gets
surrogacy regulation right, all things considered. It grants, for instance, that “a surrogate
(gestational and traditional) has at least seven days [after birth] to change her mind about
parentage, and requires joint medical decision-making between the parents and the
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surrogate in the interim…” (Cohen 2016).

It is beyond the scope of this chapter to

comment on whether provisions like a seven-day waiting period before parentage is
assigned are appropriate. In general, it is not my intention to make claims about which
party is truly the ‘parent’ or ‘parents’ of the children created through surrogacy. Rather, I
merely argue that when it comes to the doctor-surrogate relationship, the fact that the
surrogate won’t parent the child she gestates should not influence the doctor’s medical
judgments any more than it would in adoption cases.
I will address two final objections to my recommendations. The first is that
requiring separate advocate teams and alternative payment arrangements may make
surrogacy even more expensive than it already is. This may significantly reduce the
number of surrogacies taking place in general. Moreover, it may also effectively limit
access to surrogacy to only the very wealthy. Reducing the number of surrogacy
arrangements taking place is not a genuine worry, however. If the cost of ensuring that
doctors prioritize the health interests of surrogates is an overall reduction in the number
of surrogacy arrangements taking place, then that is a reasonable price to pay. Doctors are
under no moral obligation to provide infertile couples with access to surrogacy, while
they are under an obligation to avoid situations where they face serious conflicts of
interest.
The concern with limiting access to surrogacy to only the very wealthy is more
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These regulations only apply to altruistic surrogacy arrangements since commercial

surrogacy is illegal in Canada.
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troubling from the standpoint of fairness. Some may argue that if only affluent infertile
individuals are able to access surrogacy services, this may be unfair to less affluent
prospective parents. Moreover, if surrogacy is only accessible to the very wealthy, this
may further exacerbate the power imbalance that often exists between commissioning
couples and surrogates. A criticism that feminists often level against the commercial
surrogacy industry is that it creates a system of stratified reproduction, where privileged
individuals make use of the reproductive capacities of less privileged women to further
their family formation goals (Twine 2011, 16).
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Making surrogacy even more expensive

may serve to further the economic gap between those accessing and those providing
surrogacy services.
These concerns with fairness are difficult to overcome, and it is beyond the scope
of this chapter to thoroughly address them.
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Most responses go far past the question of

doctors’ conduct within surrogacy. Dominique Martin and Stefan Kane (2014), for
example, have proposed a model of national self-sufficiency in reproductive resources,
where countries aim to meet their citizens’ reproductive assistance needs domestically.
This model would “require a complete overhaul of policies and practices concerning
procurement, use, and distribution of gametes and surrogacy services” (Martin and Kane
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For further discussion of stratified reproduction, see Whittaker and Speier (2010);

Mohaptra (2012); Deomampo (2016).
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A discussion of the issue of unequal access to reproductive treatment also takes place

in the debate surrounding the public funding of IVF (Panitch 2014; McLeod 2017).
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2014, 31). Such a model would reduce the stratification of reproduction by promoting
greater reciprocity in the giving and receiving of reproductive services. A self-sufficiency
model could also include increased public funding for surrogacy services, and also for
infertility prevention. This would alleviate the financial burden of accessing surrogacy
and also reduce the potential for financial conflicts of interest. However, the notion of
publically funding surrogacy services brings up additional ethical concerns. For instance,
publically funding surrogacy may end up imposing disproportionate burdens on women
57

since they would be the ones called upon to provide gestational labour.

The overall

demand for surrogates may also increase if surrogacy is publically funded, potentially
putting additional pressure on women to become surrogacy providers.
Although I am unable to thoroughly explore remedies to the problem of fairness
here, it is worth emphasizing that inequalities already plague surrogacy. At worst,
through increasing the costs associated with surrogacy, my recommendations would only
potentially exacerbate them. However, my proposed changes can also work to reduce
unfairness. For example, as discussed above, commissioning couples often have the
power to influence the medical decisions made by surrogates’ doctors. If the doctorsurrogate relationship is better insulated from commissioning couples’ influence, then
this may reduce the power they have over surrogates. While the economic gap between
commissioning couples and surrogates may not necessarily be lessened, the problematic
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The burden may, of course, also fall upon those who have the capacity to gestate

children but do not identify as women.
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power imbalances that can flow from that gap would indeed be reduced.
The second objection to my recommendations is to do with enforceability. As
discussed above, commercial surrogacy often takes place transnationally, standards of
care are variable, and doctors’ roles within surrogacy are diverse. It would therefore be a
difficult task to ensure that surrogacy arrangements adequately safeguard the doctorsurrogate fiduciary relationship in practise. To respond to this worry, I will simply
reiterate that I am concerned primarily with making a normative argument about doctors’
participation in commercial surrogacy. Doctors must be able to act loyally while
facilitating surrogacy arrangements in order for their actions to be permissible. This
requires considerable departure from the practises of commercial surrogacy as they
commonly occur. Ensuring that doctors do, in fact, live up to these standards of fiduciary
loyalty may require a paradigm shift on the part of both the countries that allow for
commercial surrogacy and also the countries that grant citizenship to children born to
surrogates abroad. It is my hope that recognizing both doctors’ fiduciary obligations to
surrogates, and also the ways in which commercial surrogacy arrangements can
undermine those duties, will help spur change in that direction.

3.3 Conclusion
In this chapter, I have explored how recognizing the doctor-surrogate relationship as
fiduciary can provide guidance regarding fertility doctors’ participation in commercial
surrogacy. First, I argued that commercial surrogacy arrangements, as they commonly
take place, often undermine doctors’ ability to uphold their fiduciary duties. Then, taking
inspiration from other ‘dual loyalty’ contexts (sports medicine and live organ donation), I
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argued that surrogacy arrangements could be structured so that the doctor-surrogate
relationship is better insulated from the undue influence of secondary interests. I argued
that (1) payments to surrogates’ doctors should not come directly from commissioning
couples, (2) single embryo transfer should be adopted as the standard of care, and (3)
there must be clear separation between the commissioning couple and the doctor(s) who
treat the surrogate in all cases. Although commissioning couples can reach agreements
with surrogates about certain aspects of her pregnancy, doctors should be under no
obligation to uphold or enforce the terms of their contracts. I concluded that adopting
these recommendations would help ensure that doctors can wield the discretionary power
they have over surrogates’ health interests in a manner consistent with their fiduciary
duty of loyalty.
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Chapter 4

4

Fertility Doctors’ Duties to Future Children
In the previous two chapters, I primarily discussed the fiduciary relationships that

arise between doctors and surrogates, and how commissioning couples’ interests may
influence those relationships. However, as I alluded to in Chapter 3, surrogates and
commissioning couples are not the only parties whose interests are at stake in surrogacy
arrangements. The primary goal of surrogacy is to bring a child into the world. Thus, it
stands to reason that a consideration of children’s interests may come into play when
exploring doctors’ obligations. Indeed, there is some indication in the surrogacy literature
that in practice, doctors prioritize not only the interests of the commissioning parents, but
also the interests of the children produced through surrogacy arrangements.
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Recall, for

I should note that since the commissioning couple has a strong interest in the live birth

of a healthy infant, their interests are often intertwined with the well-being of the child.
For instance, interventions like medically unnecessary cesarean sections are framed both
as being for the benefit of the commissioning couple and also for the benefit of the child.
As aforementioned, Tanderup et al. (2015b) reported doctors defending the routine use of
C-sections by claiming, “No one wants to risk a vaginal delivery when it is such a wanted
child,” and, “These parents have been through so much, so we don’t want to risk a
stillbirth or other complications… So, for them even that 1 per cent or 0.1 per cent chance
of having, say a catastrophe during labour … is a risk no one would like to take” (498).
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instance, the testimony of the Indian surrogate interviewed by Pande regarding her
doctors’ apparent priorities when it came to delivery method: “It’s not like there can’t be
normal [vaginal] deliveries in this process but they don’t want to take any risk. The child
is most important, not our bodies [emphasis added by Pande]” (Pande 2014, 117). Such
an attitude raises questions about how doctors ought to view their responsibilities towards
the children they help create through surrogacy.
To answer these questions, I first explore both how children’s interests are at
stake in surrogacy arrangements, and also how various regulations impose obligations on
fertility doctors vis-à-vis those interests. Then, I consider what potential grounds there are
for imposing such obligations. I begin by considering a causal account of doctors’ moral
obligations. The causal account suggests that since doctors are, in part, causally
responsible for the creation of these children, they are also morally responsible for their
creation. However, I argue that the causal account of doctors’ responsibility ends up
implying that doctors have parental-like obligations to the children they help create,
which is highly counterintuitive.
Rather than adopt a causal view of responsibility, I argue that what generates
fertility doctors’ obligations is that their role in the creation of children involves them
wielding discretionary power over those future children’s interests. I argue that doctors
wield this power as part of a fiduciary mandate created by the state to protect the
vulnerable interests of the children produced through surrogacy and other forms of
assisted reproductive technology. Thus, I conclude that they have a fiduciary obligation
to these children. In making this argument, I distinguish what I call pre-conception
obligations from post-conception obligations, and argue that doctors’ post-conception
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obligations to future children are contingent upon doctors’ receiving authorization from
the pregnant woman to act in her future child’s interests.
Finally, I address two objections to the fiduciary account of doctors’ obligations
to the children they help create through assisted reproduction. The first objection is that if
a doctor has fiduciary obligations to future children, this may generate a conflict of
interest for doctors between the pregnant woman (either a surrogate or an infertile patient
in other forms of ART) and the future child. Since the duty of loyalty requires that
fiduciaries avoid conflicts of interest, this suggests that doctors ought to avoid becoming
involved with the provision of assisted reproductive services. I address this objection by
arguing that a concern with the welfare of future children is a legitimate part of doctors’
larger mandate to act in the public good. Therefore, conflicts that arise between the
interests of prospective surrogates/fertility patients and future children do not give rise to
divided loyalties. The second objection is that the ‘non-identity’ problem poses a
challenge to my view, given that my view implies that a doctor could be acting in the best
interests of a future child by refusing to bring him or her into existence (Cohen 2011). I
address this concern by appealing to the notion that doctors’ duties to future children are
more structural than interpersonal. That is to say, their duties attach to whoever occupies
the position of ‘future child’ rather than to specific, identifiable future persons.

4.1 Surrogacy, ART, and Children’s Interests
Many philosophers, legal theorists, and policymakers have written on the impact
surrogacy may have on the children created through it. These analyses often consider
how surrogacy practices relate to children’s rights (Hanna 2010; Ergas 2013; Gerber and
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O’Byrne 2016), whether surrogacy involves baby-selling or otherwise commodifies
children (Anderson 2000; Allan 2014; Watson 2016), or whether surrogacy is inherently
harmful to children (Agnafors 2014; Baylis 2014; Overall 2015). It is beyond the scope of
this chapter to fully engage with this literature. For the sake of argument, I proceed under
the assumption that surrogacy, at least in principle, need not be harmful to children. That
is, I assume that surrogacy does not inherently violate children’s human rights, and that
there is no intrinsic reason why doctors who are concerned for children’s welfare must
refuse to provide surrogacy services outright.
However, even proceeding under the assumption that surrogacy is not intrinsically
harmful to children, there are still aspects of the commercial surrogacy industry that raise
concerns about children’s interests. Take, for instance, the case of baby Gammy, whose
birth to a Thai surrogate provoked widespread anger about transnational surrogacy and
ultimately contributed to Thailand banning foreign nationals from hiring Thai surrogates.
In December 2013, a Thai surrogate named Pattaramon Chanbua gave birth to twins who
had been commissioned by an Australian couple, David and Wendy Farnell. According to
some reports, ultrasound results had indicated that Pattaramon Chanbua was carrying
twins and that the male twin had Down syndrome (Murdoch 2014). The couple
reportedly requested that she undergo a selective reduction seven months into the
pregnancy and only carry the healthy female fetus to term. However, she refused and
decided to carry both fetuses to term (ibid). After the twins were born, the Australian
couple returned home with only the female infant, Pipah. The male infant, Gammy, was
left in Thailand under the care of Pattaramon Chanbua. When this story was reported in
the news, it sparked public outrage, especially since it was revealed that David Farnell
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had spent three years in prison in the late nineties for sexually assaulting two young girls.
After learning this information, Pattaramon Chanbua petitioned Australian courts for
custody of Pipah. Although the suit was unsuccessful, the conditions of the Farnells’
retaining custody over Pipah included regular home visits from the Department of Child
Protections, and the requirement that they must comply with a safety plan that prohibits
Pipah from being left alone with Mr. Farnell so that he cannot “groom her” (McNeill
2016).
The case of baby Gammy raised concern about whether children’s interests were
being paid due regard in surrogacy arrangements. Many had the intuition that given
David Farnell’s history of child abuse, he should not have been allowed access to
surrogacy services since he would not be a minimally decent parent. The thought that his
history of abuse portended severe inadequacies in parenting seemed validated by the fact
that he and his wife apparently abandoned their disabled child in Thailand.
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Yet, it is

unclear how their access to surrogacy services could or should have been prevented.
Although Thailand’s current regulations now prohibit international couples from
traveling to Thailand to hire surrogates, they do not prevent Thai couples from doing so
(as long as they are married).
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There are conflicting accounts as to whether the Farnells truly wanted to leave Gammy

behind (McNeill 2016). However, regardless of their intentions, the fact remains that they
were willing to leave their disabled son behind in a foreign country to be raised by
Pattaramon Chanbua while returning home with their healthy daughter.
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Some regulatory frameworks do attempt to limit access to assisted reproduction
based on the interests of children. According to Guido de Wert (1998), “Suitability for
parenthood has been widely established as a valid consideration in determining who may
60

receive infertility treatment” (230-231).

Canada’s Assisted Human Reproduction Act

(AHRA) requires that “the health and well-being of children born through the application
of assisted human reproductive technologies must be given priority in all decisions
respecting their use.” In the Australian state of Victoria, which prohibits commercial
surrogacy but allows altruistic surrogacy, any individual accessing surrogacy services or
other forms of assisted reproduction (other than self-insemination) must undergo a
criminal record check and a child protection order check.
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If an individual fails any of

these checks (i.e. if it is discovered that he or she had been convicted of a sexual offense
or violent crime, or previously had a child removed from his or her custody), then a
‘presumption against treatment’ applies. According to the Victoria Assisted Reproductive
Treatment Authority (VARTA), “treatment may also be denied because a registered ART
provider or doctor is concerned that there is a risk of abuse or neglect of a child who may
be born as a result of treatment....” (VARTA, “Refusal of treatment”). In such cases, the
individual(s) may apply to a Patient Review Panel, which considers whether there is
sufficient evidence to deny the individual access to assisted reproductive treatments. The
Panel is guided by the principles of Victoria’s 2008 Assisted Reproductive Treatment Act
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There is no universally accepted standard, however, for determining what constitutes

suitability for parenthood.
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Surrogacy laws vary state-by-state in Australia.
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(ARTA), which state that “the welfare and interests of persons born or to be born as a
result of treatment procedures are paramount” (ARTA, 5.a). The Panel is tasked with
determining, among other things, whether granting an individual or couple access to ART
is “consistent with the best interests of a child who would be born as a result of the
treatment procedure” (ARTA, 15.3.b).
The United Kingdom’s Human Fertilization and Embryology Act (HFEA) and its
accompanying Code of Practice guidance notes provide an in-depth account of how the
welfare of children born through ART ought to be protected. Section 13(5) of the HFEA
states, “A woman shall not be provided with treatment services unless account has been
taken of the welfare of any child who may be born as a result of the treatment (including
the need of that child for supportive parenting)…” HFEA guidance note “8. Welfare of
the Child,” which explains how the mandatory requirements listed in Section 13(5) of the
Act should be implemented, states that health care professionals working in fertility
centers must consider “factors that are likely to cause a risk of significant harm or neglect
to any child who may be born…” According to part 8.10:
These factors include any aspects of the patient’s or (if they have one) their
partner’s: a) past or current circumstances that may lead to any child mentioned
above experiencing serious physical or psychological harm or neglect, for
example: i) previous convictions relating to harming children ii) child protection
measures taken regarding existing children, or iii) violence or serious discord in
the family environment b) past or current circumstances that are likely to lead to
an inability to care throughout childhood for any child who may be born, or that
are already seriously impairing the care of any existing child of the family, for
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example: i) mental or physical conditions ii) drug or alcohol abuse iii) medical
history, where the medical history indicates that any child who may be born is
likely to suffer from a serious medical condition, or iv) circumstances that the
centre considers likely to cause serious harm to any child mentioned above.
In addition, part 8.11 states:
When considering a child’s need for supportive parenting, centres should consider
the following definition: ‘Supportive parenting is a commitment to the health,
well-being and development of the child. It is presumed that all prospective
parents will be supportive parents, in the absence of any reasonable cause for
concern that any child who may be born, or any other child, may be at risk of
62

significant harm or neglect.’

In the UK, the health care professionals working in fertility centres are therefore held
responsible for protecting the welfare of children created through assisted reproduction
prior to and during conception, insofar as they must consider whether those children will
have access to ‘supportive parenting’ or will be at risk of significant harm or neglect,
before helping to bring them into existence. These regulations raise the question: should
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Specifically with regards to surrogacy, guidance note 8.12 also includes the provision,

“If the child will not be raised by the carrying mother, the centre should take into account
the possibility of a breakdown in the surrogacy arrangement and whether this is likely to
cause a risk of significant harm or neglect to any child who may be born or any existing
children in the surrogate’s family.”
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we hold health care professionals responsible for protecting the welfare of the children
they help produce through assisted reproduction? What might justify the imposition of
such responsibility?

4.2 The Causal Account
The most obvious explanation one might give for why fertility doctors have obligations
to the children they help create through surrogacy and other forms of assisted
reproduction is a causal one: doctors are causally responsible for the creation of these
children, and this causal responsibility carries with it moral responsibility. De Wert
endorses such a view when he explains why it is justifiable for doctors to impose a
standard of suitability upon prospective parents who wish to access assisted reproduction,
but not upon prospective parents who conceive naturally. He argues that in natural
conception, the prospective parents bear sole responsibility and decision-making
authority for reproduction. However, in the context of assisted reproduction, “a third
party is involved, namely the doctor” (1998, 231). De Wert explains, the doctor “has his
own responsibility for the consequences of his acts. A doctor assisting in reproduction
shares the responsibility for creating a new human being. Assisting in reproduction is as
little morally neutral as is reproducing” (ibid).
De Wert seems to suggest that doctors’ causal responsibility for the creation of
children grounds a pre-conception duty to consider whether prospective fertility patients
will be minimally decent parents before providing them with access to assisted
reproductive treatment. Yet, this same type of causal argument about moral responsibility
towards children has also been used to ground duties much more robust than the duty to
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ensure that prospective parents are minimally suitable. Indeed, the same type of causal
argument has been used to ground parental obligations. Jamie Lindemann Nelson (1991),
for example, argues that “parental obligation primarily stems from the parents’ role in
causing the existence of their children…” (50). She goes on to explain,
[I]n the absence of special considerations, such as force or fraud, those causally
responsible for the child’s existence—and hence, her existence as a morally
considerable being at serious risk of death, suffering and other harms—have a
particular obligation to attempt to preserve their children from such risks. This is
as much as to say, barring rape or other kinds of coercive intercourse, if you've
been involved in making a baby, you’re responsible for it, whether you consent to
such responsibility or not. (ibid)
In other words, parental responsibility is grounded in the act of voluntarily contributing
to the existence of “specific valuable and vulnerable beings” who have needs and who
will suffer greatly if those needs are not met (Nelson 2014, 190).
Nelson argues, further, that not all actors implicated in the causal chain of events
leading up to the creation of a child acquire parental obligations. A banker who provides
a couple with a loan to finance their fertility treatment would not, for instance, acquire
parental obligations to the subsequently produced child. To determine which causal
agents acquire parental obligations, Nelson appeals to the roles played by sufficiency and
proximity in causation. She claims that in the absence of special mitigating factors,
actions that are proximate to and jointly sufficient for a particular event are typically
regarded as being that event’s cause. When it comes to parental obligation, Nelson argues
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that “the making available of one’s gametes is an act highly proximate to conception,
and, in concert with the other parent’s actions, is jointly sufficient for it” (1991, 54). This
implies, according to Nelson, that any person who has contributed their gametes to
conception (not only individuals actively attempting to conceive, but also sperm and egg
providers, one-night stands, and sexual partners who have no interest in being parents),
have parental obligations to the subsequently created children.
Yet, the limiting criteria of proximity and joint sufficiency do not seem to rule out
fertility doctors as potential bearers of parental responsibility. In the context of assisted
reproduction, the actions of the doctors involved are proximate to conception, arguably
more so than a sperm or egg provider who may have contributed gametes months or
years prior to conception. Furthermore, the actions of the fertility doctor, when done in
concert with the actions of the intended parents, are jointly sufficient for the creation of
63

the child.

Should we therefore conclude that doctors have parental responsibility to the

children they help create through ART? Such a view would strike many as implausible.
For one thing, it would imply that doctors have a duty to ensure that children’s needs are
met throughout their lives, and to step in if those needs are not being met. This would be
highly burdensome for fertility doctors, who likely help create hundreds if not thousands
of children over the course of their careers.
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Moreover, in such cases, the actions of the prospective parents alone would not be

jointly sufficient for the creation of a child. I thank Charles Weijer for this point.
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Nelson addresses this worry by introducing a further criterion: irreplaceability.
She argues that gamete providers are “irreplaceably involved in the production of the
child in a way that other causal agents (apart from the mother) are not” (59). The thought
seems to be that other causal agents, including the doctors involved in assisted
reproduction, are more fungible than gamete providers, and are therefore less implicated
in the causal chain that leads to moral responsibility. A causal agent is understood as
irreplaceable if he or she plays, as Tim Bayne (2003) puts it, “a crucial role in fixing the
identity of the child” (81). Fertility doctors, according to Nelson, are interchangeable in a
way that gamete providers are not when it comes to the setting of a child’s identity.
However, as Bayne points out, fertility doctors do engage in certain medical
interventions that would qualify as ‘identity-determining’ (2003, 81). For instance, some
forms of mitochondrial replacement therapy (such as Maternal Spindle Transfer, which
involves removing the maternal spindle from the egg of a woman suffering from a
mitochondrial disorder and placing it in a healthy enucleated donor egg prior to
fertilization) alter the genetic makeup, and therefore arguably the identity, of the resulting
child (Wrigley, Wilkinson, and Appleby 2015).
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Nelson could respond by arguing that

the doctor who performs the Maternal Spindle Transfer is still more fungible than the
gamete provider. A different doctor could have performed the same identity-determining
procedure. However, this response ultimately ends up collapsing the causal account into a
mere genetic account (that is, an account that views parental responsibility as a product of
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More generally, fertility doctors select which eggs to fertilize and which embryos to

transfer, which can also be understood as identity-determining acts.
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genetic connection) (Bayne 2003, 78, 81). As Bayne explains, “What’s doing the work
here isn’t the role of the gamete donor as an efficient cause of the child, but the
structuring role of ‘their’ gametes” (2003, 81). If a causal account is to avoid this collapse
into geneticism, it seems as though it must accept that fertility doctors too have parental
responsibility. Such an implausible conclusion constitutes a good reason to reject a causal
account of parental responsibility altogether.
To return to De Wert, when he suggests that doctors have moral responsibility
towards the children they help create through assisted reproduction, he is presumably not
suggesting that doctors should have parental obligations to these children. The
responsibility he has in mind is clearly a pre-conception obligation to use assisted
reproductive technologies in a manner consistent with the interests of the children
potentially created through them, rather than an on-going parental responsibility to ensure
that those children’s needs are being met. If not causal responsibility, then what might
ground this type of obligation? Is there a justification for doctors’ refusing, for example,
to provide demonstrably unfit individuals with access to ART that does not rely on giving
special moral significance to their causal role in the creation of children?

4.3 The Fiduciary Account
In this section, I argue that fertility doctors have fiduciary obligations to the children they
help create through ART. I argue that fertility doctors’ obligations arise not because they
are causally responsible for the creation of these children, but rather because doctors
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make discretionary judgments about those potential children’s interests.
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In providing an

individual or couple with access to ART, a doctor actively makes discretionary
judgments that will greatly impact the interests of a potential future child. If a doctor
provides a couple who are demonstrably unfit for meeting a future child’s needs with
access to ART, this will likely have a significant negative effect on that child’s welfare.
The same could be said were a doctor to use ART to create a child with a painful,
debilitating condition or otherwise make use of these technologies in a negligent manner.
What is relevant for grounding doctors’ duties, I claim, is not that doctors are causally
responsible for the creation of vulnerable individuals with needs that must be met, but
rather that potential future children’s significant practical interests are highly vulnerable
to doctors’ use or misuse of discretionary power.
As discussed extensively in the preceding chapters, fiduciary relationships arise
when one party exercises discretionary authority over the significant practical interests of
another. If it’s true that fertility doctors make discretionary judgments regarding the
welfare of the children they help create, then doctors’ obligations to these potential future
children could indeed be viewed as fiduciary. Taking a fiduciary approach to
understanding fertility doctors’ obligations to future children is attractive because, unlike
the causal approach, it can offer an account of responsibility that is sufficiently narrow in
scope. If obligations to future children arise from exercises of discretionary power, this
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Importantly, I am not arguing that doctors have anything akin to parental obligations.

Although both doctors and parents may act as fiduciaries, the scope of their fiduciary
authority over children is very different.
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helps explain why many causal actors (such as lab technicians, clinic support staff, or
bankers who finance fertility treatments) do not have these obligations. Of course, many
individuals who play important causal roles in the creation of children through assisted
reproduction take actions that will affect the future interests of those children. However,
those actions do not involve wielding any authority to act relative to future children’s
significant practical interests. As I will explain, the actions taken by fertility doctors
during and prior to conception do involve the exercise of this type of power, and thus
fertility doctors can be understood as fiduciaries to the future children they help create.
However, before I can argue for this position, I must establish that fiduciary
duties are the sorts of things that can actually attach to future persons. Certainly, most
fiduciary relationships arise between entities or individuals who currently exist. These
relationships typically involve an identifiable beneficiary authorizing a fiduciary to act on
her behalf, as is commonly the case in doctor-patient relationships. Yet, not all fiduciary
relationships involve a clearly identifiable beneficiary. P. B. Miller and Andrew Gold
(2015) argue that there are two types of fiduciary mandate: service-type mandates and
governance-type mandates. Service-type fiduciary mandates, which are the most common
type of fiduciary mandate, exist to serve the interests of determinate persons. The
fiduciary mandate of a lawyer is to represent the interests of her client, for instance. The
service-type mandate is the type of fiduciary mandate I have been discussing when
considering the doctor-surrogate relationship. On the other hand, governance-type
fiduciary mandates arise in order to determine or advance certain abstract purposes, such
as in the administration of a charitable trust to promote literacy. In governance-type
fiduciary relationships, “[t]he powers of the fiduciary, and the objects for which he acts,
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are specifiable entirely with reference to one or more abstract purposes without it being
necessary to identify a beneficiary, much less the particular interests or preferences of
that beneficiary,” (P. B. Miller and Gold 2015, 4). According to P. B. Miller and Gold,
fiduciary mandates can therefore exist without identifiable beneficiaries whose “personal
practical interests in the mandate are ascertainable ex ante and whose interests are
protected through personal enjoyment of rights or powers relative to the mandate” (2015,
8). Governance-type fiduciary mandates are held relative to collectives whose
membership may be more determinate (such as particular communities) or less
determinate (such as members of a socio-economic class). These types of fiduciary
relationships are institutional, rather than interpersonal, and are maintained through legal
offices that may be occupied by various individuals over the course of many years.
Fiduciary authority in governance-type relationships is derived from a benefactor
empowering a fiduciary office to act in order to pursue an abstract purpose. Individuals
other than the beneficiaries themselves can thus grant fiduciary authority.
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Moreover,

since the mandate of a fiduciary institution can be specified without having to identify
particular beneficiaries, it can theoretically be constructed so that the beneficiaries are
persons who do not yet exist. For example, one could imagine a charitable trust initiated
to aid individuals displaced as a result of climate change, which had been set up such that
all of its beneficiaries are people who will be born years from now. P. B. Miller and
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Individuals other than beneficiaries can also grant fiduciary authority in service-type

relationships. For instance, as I mention below, parents can grant doctors fiduciary
authority over their children’s interests.
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Gold’s work therefore offers an account of how it is possible to have fiduciary duties to
future persons. Such a view supports claims made by some in the realm of environmental
law about fiduciary obligation and the interests of future persons. Ken Coghill, Charles
Sampford, and Tim Smith (2012), for example, have suggested that the principles of
fiduciary duty may help guide how governments protect the interests of future
generations from the harms of anthropogenic climate change.
Given that it is possible for individuals who do not yet exist to be beneficiaries in
fiduciary relationships, I can now return to my analysis of the doctor-future child
relationship. Potential future children are indeterminate beneficiaries insofar as their
specific interests and identities are unknowable ex ante. In that sense, they are different
from the type of beneficiary typically involved in service-type fiduciary relationships.
Yet, future children are more determinate than the highly abstract beneficiaries that
governance-type mandates seem to involve (for example, “the public”). When a doctor is
considering a particular request for ART, she must consider not how her decisions would
affect future children in general, but rather how they would affect a particular future
child, who would be born to particular parents or have certain features (such as a genetic
condition). Thus, whatever the relationship between fertility doctors and the children they
help create through assisted reproduction is, it does not fall neatly under the category of
either type of fiduciary mandate.
Is there a middle ground between these two types of mandate? Is it possible to
have a relationship that involves features of both service-type and governance-type
fiduciary relationships? P. B. Miller and Gold actually describe some relationships that
involve “a hybrid mandate involving service and governance elements” (580). One
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example of a hybrid fiduciary mandate is the mandate that governs public benefit
corporations. Public benefit corporations have two types of beneficiaries: the company’s
shareholders and the public. As a for-profit company, the corporation’s board has
fiduciary duties to its shareholders. As a corporation that exists for the public benefit, the
pursuit of shareholder’s pecuniary interests is tempered by corporate commitments to
certain public goods.

67

However, in this case, the hybrid character of the mandate is the

result of there being two classes of beneficiary. What I have in mind when it comes to
doctor-future child relationships is a class of beneficiary that is itself ‘hybrid,’ which
comprises neither concrete individuals nor abstract purposes, but rather particular future
persons.
To the best of my knowledge, there has yet to be a discussion in the literature on
fiduciary relationships that considers this type of ‘hybrid’ beneficiary. However, I argue
that if fiduciary obligations can attach to both individuals and also future generations,
there is no principled reason to exclude future individuals. What remains to be
established is whether or not there can actually be any fiduciary authority in such cases.
In order for the relationship between doctors and the future children they help create
through assisted reproduction to be fiduciary, doctors must wield discretionary authority
over those future children’s significant practical interests. When fertility doctors make
decisions about whether or not to grant couples access to ARTs, they are certainly
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One could potentially make the argument that doctors in general also have, in some

sense, a hybrid fiduciary mandate since they have duties both to their patients and also to
the public.
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exercising power over the significant practical interests of any future child that is created.
This power is discretionary in nature since the doctor is ultimately the one who makes a
decision about whether to provide access to ARTs and how these technologies will be
administered based on her own professional judgment.
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But is this power truly

authority? A potential future child is clearly unable to authorize a doctor to make
decisions on her behalf. So where would the authority to act on the potential future
child’s behalf come from?
In general, when doctors treat children, they do so on the basis of the authority
granted to them by the child’s parent(s). One could argue that in seeking out assisted
reproduction, an individual grants a doctor a similar type of authority, namely the
authority to act on behalf of their future children. However, in the standard doctor-child
relationship, the parent usually retains final decision-making authority, and is allowed to
refuse a doctor’s medical recommendations for her child. It would seem that if a doctor
wishes to refuse to grant an individual access to ART out of concern for a potential future
child’s interests, the prospective parent should similarly be entitled to refuse to take the
doctor’s recommendation. Why should the parent retain decision-making authority in the
former case, but not in the latter?
To answer this question, I note that there are instances when parental authority
over a child’s medical treatment can be overridden. For instance, according to a 2004
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As I will discuss below, doctors do not necessarily have expertise in evaluating

parental suitability.
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position statement by the Canadian Pediatric Society:
When the physician and health care team believe that parental decisions are
clearly inconsistent with the child or adolescent’s best interests, the assistance of
an institutional ethics committee or ethics consultant is recommended. If this is
not available or the conflict is not resolved at this level, then the involvement of
local child protection authorities and the legal system may be unavoidable.
Although such a course of action is often uncomfortable for the health care team
and should only be used as a last result, its ethical basis rests soundly on the
health care professional’s duty to ensure that the best interests of the child or
adolescent are given primacy. (“Treatment Decisions Regarding Infants, Children
and Adolescents,” 102-103)
Thus, medical professionals can seek to override parental decision-making authority if
the child’s interests are not being adequately protected. Such considerations therefore
point towards the state as an additional source of fiduciary authority over children’s
interests.
I suggest that, at least in countries where the state licenses fertility doctors to
provide ARTs and requires that they consider the welfare of the children they help create
through their use of such technologies, the state effectively creates a fiduciary mandate
for fertility doctors to protect the interests of potential future children. Although the
specific interests of these potential children cannot be known ex ante, all future children
have basic significant practical interests, such as an interest in having access to minimally
decent parenting and an interest in not being born with preventable, highly debilitating
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conditions.
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Fertility doctors have discretionary power over these interests insofar as

they are both the gatekeepers to accessing ART, and also the providers of these
treatments (who play a large role in determining which technologies will be used and
how they will be administered). I therefore claim that fertility doctors can have
obligations to the children they help create through assisted reproduction as part of a
fiduciary mandate created by the state.
In making this argument, it is useful to note the interplay between recognizing
that a given relationship involves the kind of structural vulnerability inherent in fiduciary
relationships and creating fiduciary mandates. Recall that in Chapter 1, I defended Evan
Fox-Decent’s (2005) view that in some circumstances, it is sufficient for the
establishment of a fiduciary relationship “that the fiduciary has discretionary control over
the vulnerable interests of another party which themselves are capable of forming the
subject matter of a fiduciary obligation” (294). In such cases, fiduciary mandates are
created out of the recognition that one party has discretionary control over the vulnerable
interests of another. I argue that when legislation requires that doctors consider the
welfare of potential future children, it does so out of recognition that those children’s
significant practical interests are highly vulnerable to the decisions made by fertility
doctors. It is this legislation that grants doctors the authority to act on behalf of these
potential future children since they cannot authorize doctors themselves. Thus, there is
both an element of recognition and of creation when it comes to the fiduciary obligations
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The conditions I have in mind are not ones like deafness, which is arguably not

debilitating, but rather painful, life-shortening conditions like Tay-Sachs disease.
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fertility doctors have to potential future children. In the absence of such legislation,
doctors may not actually have the authority to make decisions on behalf of potential
future children (such authority resides with the pregnant woman, unless she grants it to
her doctor). However, recognizing potential future children’s vulnerability to doctors’
decisions could provide a compelling reason for the state to create a fiduciary mandate.
Finally, when discussing the fiduciary obligations of fertility doctors, it is helpful
to clarify at what juncture(s) doctors actually have discretionary authority over the
interests of potential future children. I have thus far been discussing doctors’
discretionary powers in pre-conception decision-making—that is, in making decisions
about whether to provide access to ART, what particular technologies to make use of, and
how to provide them. These decisions concern future children who may or may not be
conceived. However, one may also wonder whether doctors have post-conception
discretionary authority over the future children they help create. That is, one may wonder
whether doctors also have fiduciary duties to future children once they are instantiated as
fetuses.
Before addressing this question, I want to emphasize that there is, in general, an
important moral distinction between fetuses and future children. Bonnie Steinbock (2011)
makes this distinction when she argues that the moral obligations that pregnant women
have change if and when they decide to carry their fetus to term. She states, “Once this
decision [to carry a fetus to term] is made, the fetus is not simply a potential child. It will
be a child who, once born, has interests, including an interest in a healthy life” (Steinbock
2011, 31, my emphasis). On this account, we should view fetuses as being future children
only when a pregnant woman decides to bring that child to term. The fetus is morally
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considerable at that juncture not because it has interests qua fetus, but rather because it
will one day have interests qua person. Anne Lyerly, Margaret Little, and Ruth Faden
(2008) make a similar distinction when they argue that medical professionals acquire
duties to fetuses that are not simply derivative of their duties to their pregnant patients
only when those patients decide to continue with their pregnancies (42). In short, fetuses
should be thought of as future children only so long as the pregnant woman intends to
70

carry them to term.

This distinction means that one can accept the view that doctors can

have fiduciary duties to future children without having to accept that doctors necessarily
have duties to all fetuses. Therefore, my view about doctors’ duties to future children
does not provide any justification for limiting access to abortion.
Bearing this distinction in mind, I argue that doctors can have fiduciary duties to
fetuses, but only in cases where they genuinely have discretionary authority over that
fetus’s (qua future child’s) significant practical interests. Fertility doctors may continue
to have post-conception power over the interests of the future children they help create,
insofar as they have the ability to intervene in a woman’s pregnancy in ways that can
affect the resulting child’s future welfare. However, this does not mean that they have the
authority to do so. Once that future child resides in the body of a woman, she is the one
who now has authority over its interests. This is because, as Rosamund Scott (2002)
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My view implies that if a pregnant woman who previously had wanted to carry her

fetus to term changes her mind, then her doctor should no longer view her fetus as a
future child. For the sake of brevity, I put aside debates about the moral status of viable
fetuses.
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argues, her body is implicated in any decision made about the fetus. Her right to bodily
integrity and self-determination are therefore inextricably at stake (Scott 2002, 24-25).
Doctors simply do not have the authority to override competent adults’ decision-making
about their own bodies. They do not, therefore, have authority over the interests of future
children post-conception. That said, it is possible for pregnant women to grant authority
over the interests of their future children to doctors. Imagine a case where a doctor
discovers that a fetus, which a pregnant woman intends to bring to term, suffers from
myelomeningocele (a defect wherein the spinal cord does not form or close normally),
and that fetal surgery is a viable option for treatment. In this case, the pregnant woman
may consent to surgery and authorize the doctor to wield discretionary power not only
71

over her interests, but also over the interests of the fetus.

In this case, I claim that the

doctor would have fiduciary obligations to the fetus qua future child.

4.4 Objections
In this section, I address two objections to the notion that fertility doctors have a fiduciary
mandate to act in the interests of the children they help create through assisted
reproduction. The first is the divided loyalties objection, which argues that if doctors have
fiduciary duties to future children, this may create a conflict of interest between the future
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Again, I am understanding the interests of the fetus as the interests of a future person,

not as the interests of a fetus qua fetus. It should also be noted that the interests of the
pregnant woman and the fetus are deeply intertwined, and it is difficult to conceptually
separate them.
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child’s interests and the pregnant woman’s interests. Since fiduciaries must avoid
conflicts of interest, they should therefore avoid any situation where their loyalties to
their pregnant patients clash with their loyalty to the future children they help create. That
is, they should refrain from providing ART services. The second objection is the nonidentity problem objection. This objection implies that, on my view, a doctor can
discharge her fiduciary obligation to a potential future child by refusing to bring that
child into existence. This implication strikes some as implausible since they claim that
even if a particular child would have unsuitable parents or suffer from a debilitating
genetic condition, it would still be in her best interest to be brought into existence.

4.4.1

The Divided Loyalties Objection (A Reprise)

In section 4.3, I claimed doctors do not wield fiduciary authority over the interests of
future children when there is an established pregnancy (beyond whatever authority is
granted to them by the pregnant woman). Thus, no conflict of interest arises. However,
one may question whether, prior to conception, there is a genuine conflict between the
interests of future children and the interests of surrogates or prospective fertility patients.
Recall that fiduciaries have an obligation to act loyally to their beneficiaries, which
includes the obligation to avoid conflicts of interest. That is, fiduciaries must avoid
situations where their professional judgment or actions will be unduly influenced by a
secondary interest. If there is a case in which a doctor has a fiduciary obligation to both a
potential future child and also to a prospective parent or surrogate, then this may give rise
to a conflict of interest since the interests of the respective parties may clash. For
example, returning to the hypothetical case of Anna and Dr. Brown from the previous
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chapter, imagine a situation where Anna is an individual struggling with fertility who
goes to Dr. Brown, a fertility specialist, for tests. The tests determine that Anna is unable
to carry a child to term. So, Anna decides to pursue surrogacy as an option, and finds a
woman, Connie, willing to serve as her gestational surrogate. Anna returns to Dr. Brown
and requests assisted reproductive treatments as part of the surrogacy process. In this
case, a clear doctor-patient fiduciary relationship has been established between Anna and
Dr. Brown since Dr. Brown had been performing medical tests on Anna and providing
her with diagnoses. However, imagine further that while discussing the treatments with
Dr. Brown, Anna discloses that she chose to pursue surrogacy because she knows she
would be unable to adopt due to prior convictions regarding child abuse. At this point Dr.
Brown feels conflicted. If, as I argued in the previous sections, Dr. Brown has a duty to
protect the interests of the children she helps create through assisted reproduction, she
ought to refuse to provide Anna with ART treatment. Yet, as her doctor, Dr. Brown also
has a fiduciary relationship with Anna, which means Dr. Brown must loyally act in
72

Anna’s interests when it comes to her medical treatment.

In general, if doctors have a

fiduciary duty to act in the interests of potential future children, and also a fiduciary
obligation to act in the interests of individuals seeking access to ART, this appears to
routinely generate conflicts of interests for fertility doctors. Should doctors therefore
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There might be some disagreement as to whether a desire to have a child through

assisted reproduction rises to the level of a significant practical interest. If it does not
qualify as a significant practical interest, the divided loyalties objection would not arise. I
thank Dennis Klimchuk for this point.
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refuse to become involved in the provision of assisted reproductive services to avoid such
conflicts and uphold their fiduciary duties? This would certainly be an undesirable
situation.
This is a challenging objection. Is it possible to maintain that doctors have duties
to potential future children without placing them in situations of divided loyalties? To
answer this question, I return to an argument from Chapter 1 regarding the nature of
fiduciary loyalty. In that chapter, I claimed that not all instances of multiple loyalties rise
to the level of divided loyalties. I defended the view that loyalty is a matter of motive: a
fiduciary can be understood as acting loyally when her actions are motivated by a good
faith desire to use her discretionary power in order to achieve the ends for which she was
empowered in the first place. For instance, if I am the CEO of a company, I am acting
loyally when I use my power over that company’s resources in order to produce optimal
returns for my shareholders (rather than using my power to personally profit or sabotage
the company). Further, I claimed that the social role of doctors involves the expectation
that the profession will address certain issues pertaining to the public good, even if this
means sometimes prioritizing the public good over the wants of a particular patient (such
as in disease outbreak crises). Given that social role, I argued that if doctors use their
discretionary power over patients partly in service of the larger obligations they have to
society qua medical professionals, this ought not to be viewed as disloyalty. This is
because patients grant doctors power over their interests not only with the goal of
promoting their health as individuals, but also insofar as they are members of a society
that has a collective interest in the public good.
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Returning to the case of assisted reproduction, I argue that the medical profession
is entrusted with the responsible use of ARTs as part of society’s broader interest in
protecting vulnerable persons from harm. Thus, if a doctor refuses to provide access to
ART services out of concern for the interests of potential future children, this can be a
legitimate use of her discretionary power, even if it means she ultimately does not fulfill
the immediate wants of the prospective parents or surrogate. This is, I argue, a case where
a doctor has multiple loyalties, not divided loyalties. After all, doctors do not have a
fiduciary obligation to provide patients with access to any medical treatment they desire.
Rather, doctors should act in the best interests of their patients in a way that is consistent
with fulfilling their social role as doctors. It would be unethical for a doctor to singlemindedly pursue the interests of her patients with no regard for how any of her actions
may affect other parties (for example, by helping her patient unfairly circumvent a
waiting list to receive an organ transplant).
In addition, when it comes to infertile prospective parents, I argue that these
patients have a strong interest in having children who are emotionally and physically
healthy.
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If individuals seeking out assisted reproduction have demonstrated a clear

inability to provide minimally decent parenting (for instance, by having a prior
conviction for abusing children), then it may truly not be in their interests, broadly
construed, to have access to assisted reproduction. Returning to the case of a doctor
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It is not obvious that the same could be said about surrogates. Although, one could

potentially argue that surrogates do have an interest in producing healthy children who
will be adequately cared for since doing so is in the public good.
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quarantining a contagious patient, it is true that being quarantined may frustrate a patient
insofar as it restricts her freedom of movement. However, as a member of society, she
ultimately has in interest in not spreading a disease amongst the population. Given such
considerations, I argue that a doctor who refuses to provide access to assisted
reproduction in order to protect the interests of potential future children does not act
disloyally to her patients. Doctors’ multiple loyalties in assisted reproduction therefore do
not present a genuine conflict of interest.

4.4.2

The Non-Identity Problem Objection

A final objection to the fiduciary duties to future children view is that it faces issues of
‘non-identity.’ The non-identity problem is best understood by way of an example:
suppose an individual decides to use in vitro fertilization coupled with the genetic testing
of embryos to specifically select for a gene that causes significant health problems. The
child who is born as a result of this procedure has serious health issues, although she still
leads a life that is worth living. Some have the intuition that this action is morally
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wrong. Nonetheless, it was this very action (selecting an embryo with a genetic defect)
that brought this specific child into being. Selecting a healthy embryo would have
produced a child non-identical to the child who was born. In such a case, “we find it
difficult to explain why an individual appears to be wronged by an action that is the
condition of his or her own worthwhile existence” (Gardner 2015, 429).
Problems of non-identity present an explanatory difficulty for my account of
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Some disability rights activists may object to this line of argument.
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fiduciary duties to future persons. If a doctor has a pre-conception obligation to act in the
best interests of a potential future child, can she ever refuse to provide prospective
parents with access to assisted reproduction, so long as the child would still lead a
minimally worthwhile existence? Even if the child would be born with serious ailments
or to abusive parents, is it really in that child’s best interest to not be created?
The literature on non-identity and reproductive ethics is vast, and it is beyond the
scope of this chapter to adequately address all the issues it brings up regarding what it
means to act in the interests of future children. However, I will provide a provisional
sketch as to how my view can avoid such concerns. I mentioned earlier that governancetype fiduciary mandates are held relative to collectives whose membership may be more
or less determinate, and that the fiduciary relationships that exist under such mandates are
institutional, rather than interpersonal. That is, they are maintained through offices that
may be occupied by various individuals over time, and thus there may be no particular
fixed beneficiaries (or fiduciaries, for that matter).
This framework is applicable to understanding the fiduciary duties doctors have to
future children. I suggest that when making decisions about whether or not to provide an
individual or couple with assisted reproduction services, there is no future child with a
fixed psycho-physical identity to whom a doctor’s duties attach. Rather, the individual
towards whom a doctor has duties occupies something akin to the ‘office’ of future child.
That is, doctors’ duties attach to whoever will occupy the structural position of future
child instead of a future person with a fixed identity. This framing of fertility doctors’
duties avoids the non-identity problem since it implies that they do not have obligations
to act in the interests of future people with identities that would be altered through
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medical interventions (or lack thereof). A doctor can therefore act in the best interests of
a future child by refusing to grant demonstrably unfit parents access to assisted
reproduction since the future child who would be produced is not a beneficiary with a
fixed identity (but rather a more abstract future child). This account makes it clear that
doctors are not obligated to bring any specific person into existence. Instead, they must
simply act in the interests of whoever will occupy the structural position of ‘future
75

child.’
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It is interesting to note that my response echoes an approach to the non-identity

problem taken by Rahul Kumar (2003). Kumar considers the case of a child born with
“severe restrictions on the quality of her life,” which could have been prevented had her
parents taken appropriate precautions prior to conception, such as undergoing certain
genetic tests (2003, 99). Kumar argues that the child has been wronged, despite the fact
that had her parents undergone such tests, the child they conceived would have been nonidentical to her. To respond to this non-identity problem (i.e. how could the child have
been wronged by the very act that brought her into existence?), Kumar claims that it is
useful to distinguish between the type ‘person’ and individuals who are tokens of that
basic type. As he puts it,
A ‘type’ of person is not, of course, a substantive individual…. Rather, the ‘types’
in question are simply normatively significant sets of characteristics, whose
instantiation together may be found in actual, substantial, individuals.... An
individual, for instance, is a token of the basic type ‘person’ insofar as those facts
that are picked out by the type description ‘person’ are true of her. (2003, 111)
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4.5 Conclusion
In this chapter, I have argued that health care professionals have a fiduciary mandate to
protect the interests of the future children they help create through assisted reproduction.
First, I argued that the interests of future children are at stake in decisions about who is

Kumar argues that the type/token distinction is relevant because what matters for
understanding the prospective parents’ moral duties is that they may create an individual
who is the type ‘child’ who suffers from a serious, preventable condition. This type child
will stand in a morally considerable relationship of dependency with them, regardless of
its eventual token identity. As Kumar puts it, the fact that the “particular psycho-physical
identity of the person in question, at the point in time when compliance with the duty is
required, may still be an indeterminate matter turns out to be of no consequence,”
precisely because “the other retains her standing as a certain type to whom certain duties
are owed regardless of what her token identity turns out to be” (2003, 113). Kumar’s
type/token argument is similar to my claim that doctors’ duties attach to whoever ends up
occupying the ‘office’ of future child insofar as in both approaches, the actual identity of
the ‘office-holder’ of future child (on my account) or the token instantiation of the child
(on Kumar’s account) is not a relevant consideration. The duties in question do not flow
from a doctor or prospective parent, respectively, to a particular future child, but rather
are the product of the structural relationship between the doctor/prospective parent and
whoever that future child happens to be.
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granted access to surrogacy and other forms of assisted reproduction. Then, I explored a
causal account of why doctors might be responsible to protect future children’s interests,
and claimed that this view was not satisfactory. I argued that it is not the causal role that
doctors play in the creation of children, but rather the discretionary power doctors wield
over potential future children’s interests that is relevant. Finally, I defended the fiduciary
account from two objections: the divided loyalties objection and the non-identity problem
objection.
I want to conclude by addressing a final concern, which is that although doctors
may have the power to make decisions about who will receive assisted reproductive
services (which will greatly impact the future welfare of children created through these
technologies), doctors may not necessarily be well qualified for assessing whether a
given individual will be a suitable parent. I concede this point. Rather than having doctors
make judgments about parental suitability, it may well be preferable for the state to
introduce screening requirements for access to ART similar to those used in adoption
(such as having a social worker conduct a home study before the individual or couple is
76

cleared to access fertility services).

This way, by the time infertile individuals

approached fertility doctors to request treatment, doctors could be assured that these
individuals had fulfilled certain criteria for parental suitability. Doctors would retain
certain types of discretionary authority over the interests of potential future children, for
example, when it comes to decisions about what ARTs to use and how they should be
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administered. However, doctors would not have to consider whether infertile individuals
would be minimally decent parents. Such a system may better enable doctors to make
responsible use of assisted reproductive technologies and to protect the vulnerable
interests of future children.
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Conclusion
In my thesis, I have argued that the framework of fiduciary relationships serves as a
promising foundation upon which to ground and explicate fertility doctors’ duties in
commercial surrogacy, and also in the fertility industry more broadly. I began by
defending the view that fiduciary relationships are relationships that arise when one party
exercises discretionary authority to set or pursue the significant practical interests of
another. Given this understanding of fiduciary relationships, I argued that the doctorpatient relationship is a fiduciary relationship, and that doctors owe their patients the duty
of loyalty. Further, I claimed that despite the differences between the typical doctorpatient relationship and the doctor-surrogate relationship, the relationship between
doctors and the surrogates they treat is normatively fiduciary.
Having established that the doctor-surrogate relationship is fiduciary in nature, I
demonstrated how surrogacy arrangements give rise to serious conflicts of interest for
fertility doctors. These conflicts of interest, including conflicts of fiduciary duty and
financial conflicts, threaten doctors’ ability to act loyally to surrogates. Importantly,
although I did not claim that doctors’ involvement in surrogacy is inherently problematic,
I argued that understanding fertility doctors’ fiduciary obligations reveals that many of
the practices currently taking place in commercial surrogacy are objectionable. In
response to the concerns I raised, I made several recommendations for ameliorating
surrogacy arrangements. Taking inspiration from ethical debates surrounding divided
loyalties in sports medicine and organ donation, I argued that there needs to be greater
clinical and financial distance between commissioning couples and the doctors treating
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surrogates. To achieve this separation, I suggested that surrogates’ doctors should not be
paid directly by commissioning couples, and that fertility clinic owners should perhaps
refrain from entering into doctor-patient relationships with surrogates so as to avoid
financial conflicts of interest. Moreover, I argued that single embryo transfer should be
adopted as the standard of care to eliminate the risk that doctors could be unduly
influenced by commissioning couples’ interests or their own financial interests to attempt
to increase pregnancy success rates in a way that poses unnecessary risks to surrogates
(i.e. through multiple embryo transfer). Finally, if commissioning couples require fertility
treatment or medical information in the course of the surrogacy arrangement, I argued
that this treatment or consultation should be provided by a health care professional who is
independent from the doctor or team providing the surrogate’s care. In my future
research, I aim to consider how these recommendations can be operationalized in the
Canadian health care context, given that surrogacy is on the rise in Canada and that the
Canadian government is currently revisiting the Assisted Human Reproduction Act.
Lastly, I explored fertility doctors’ obligations to the children they help create
through surrogacy and other forms of assisted reproduction. The future interests of
children created through assisted reproduction are, I claimed, highly vulnerable to
doctors’ discretionary judgments about what types of technologies are used, how they are
used, and who is granted access to them. I argued that this vulnerability to exercises of
discretionary power can give rise to a fiduciary obligation on behalf of the doctor,
specifically under regimes where the state requires that health care professionals consider
the interests of future children when providing access to assisted reproduction. In such
cases, I argued that a fiduciary mandate is created that empowers ART providers to act in
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the interests of potential future children. However, I also conceded that doctors may not
be well equipped to make certain judgments pertaining to the welfare of future children,
such as whether a given individual requesting assisted reproductive services will be a
minimally decent parent. It may therefore be preferable for other groups, perhaps social
workers, to evaluate prospective parents to ensure that they meet certain standards for
parental suitability. Of course, there is much debate as to what constitutes parental
suitability. Yet, imposing minimal standards, such as not having criminal convictions for
child abuse or other violent crimes, may be less controversial. In the future, I hope to
develop a more thorough account of the consequences and limits of my view about
doctors’ fiduciary duties to future children. In addition, I aim to further explore what
implications my view on fiduciary duties to future persons may have for other types of
relationships, including the relationship between prospective parents and their future
children and the relationship between governments and their future citizens.
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